High-Throughput Screening (HTS) Market by Product (Instruments, Software, Service), Technology (Cell-Based Assays, Label-Free), Application (Drug Discovery, Biochemical Screening, Research), End User (Pharma & Biotech, CROs)- Global Forecast to 2025
The global high-throughput screening market size is projected to reach USD 26.4 billion by 2025 from USD 15.3 billion in 2020, at a CAGR of 11.5% during the forecast period. The growth in this market is primarily attributed to increasing R&D spending by pharmaceutical & biotechnology companies, technological advancements in high-throughput screening market and the availability of government funding & venture capital investments. Emerging markets are expected to provide growth opportunities for players operating in the high-throughput screening market in the coming years. However, costly and time-consuming nature of HTS techniques and a serious shortage of skilled operators in the industry are the major challenge in this market.
“The services segment accounted for the highest growth rate in the high-throughput screening market, by product & service, during the forecast period”
The high-throughput screening market is segmented into consumables, instruments, , services, and software. The services segment accounted for the highest growth rate in the high-throughput screening market in 2020. This segment's large share can be attributed to large pharmaceutical companies routinely engaging in outsourcing many tasks such as screening and lead identification, toxicology, and other preclinical studies.
“Contract research organizations segment accounted for the highest CAGR”
Based on end user , the high-throughput screeningmarket is segmented into pharmaceutical & biotechnology companies, academic & research institutes, contract research organizations (CROs) and other end users. In 2020, contract research organizations accounted for the highest growth rate. The major factor driving the growth of this segment is increasing trend of outsourcing of R&D activities by pharmaceutical and biotechnology companies.
“Label-free Technology segment accounted for the highest CAGR”
Based on technology , the high-throughput screeningmarket is segmented into cell-based assays, lab-on-a-chip technology, and label-free technology. In 2020, the label-free technology segment accounted for the highest growth rate. Label-free technology provides a simple assessment technique for studying complex biological pathways as it does not involve the use of labels. This will support the growth of this technology segment in the HTS market during forecast period.
“Drug Discovery segment accounted for the highest CAGR”
Based on application , the high-throughput screeningmarket is segmented into drug discovery, biochemical screening, life sciences research and other applications. In 2020, the drug discovery segment accounted for the highest growth rate. The key factor driving this segment's growth is the increasing number of clinical trials and rising pharmaceutical R&D expenditure.
“Asia Pacific: The fastest-growing country in the high-throughput screening market”
The high-throughput screening market is segmented into North America, Europe, Asia Pacific, and the Rest of the World (RoW). Asia Pacific is projected to register the highest CAGR during the forecast period. Factors such as the rising R&D spending, growing public-private partnerships, and increasing government funding are factors driving the growth of the HTS market in this region.
The primary interviews conducted for this report can be categorized as follows:
This report provides a detailed picture of the Immunofluorescence assay market. It aims at estimating the size and future growth potential of the market across different segments, such as the product, type, disease, end user, and region. The report also includes an in-depth competitive analysis of the key market players, along with their company profiles, recent developments, and key market strategies.
Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall high-throughput screening market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, trends, opportunities, and challenges.
“The services segment accounted for the highest growth rate in the high-throughput screening market, by product & service, during the forecast period”
The high-throughput screening market is segmented into consumables, instruments, , services, and software. The services segment accounted for the highest growth rate in the high-throughput screening market in 2020. This segment's large share can be attributed to large pharmaceutical companies routinely engaging in outsourcing many tasks such as screening and lead identification, toxicology, and other preclinical studies.
“Contract research organizations segment accounted for the highest CAGR”
Based on end user , the high-throughput screeningmarket is segmented into pharmaceutical & biotechnology companies, academic & research institutes, contract research organizations (CROs) and other end users. In 2020, contract research organizations accounted for the highest growth rate. The major factor driving the growth of this segment is increasing trend of outsourcing of R&D activities by pharmaceutical and biotechnology companies.
“Label-free Technology segment accounted for the highest CAGR”
Based on technology , the high-throughput screeningmarket is segmented into cell-based assays, lab-on-a-chip technology, and label-free technology. In 2020, the label-free technology segment accounted for the highest growth rate. Label-free technology provides a simple assessment technique for studying complex biological pathways as it does not involve the use of labels. This will support the growth of this technology segment in the HTS market during forecast period.
“Drug Discovery segment accounted for the highest CAGR”
Based on application , the high-throughput screeningmarket is segmented into drug discovery, biochemical screening, life sciences research and other applications. In 2020, the drug discovery segment accounted for the highest growth rate. The key factor driving this segment's growth is the increasing number of clinical trials and rising pharmaceutical R&D expenditure.
“Asia Pacific: The fastest-growing country in the high-throughput screening market”
The high-throughput screening market is segmented into North America, Europe, Asia Pacific, and the Rest of the World (RoW). Asia Pacific is projected to register the highest CAGR during the forecast period. Factors such as the rising R&D spending, growing public-private partnerships, and increasing government funding are factors driving the growth of the HTS market in this region.
The primary interviews conducted for this report can be categorized as follows:
- By Company Type: Tier 1 - 37%, Tier 2 - 22%, and Tier 3 - 41%
- By Designation: C-level - 25%, D-level - 20%, and Others - 55%
- By Region: North America -40%, Europe -27%, Asia-Pacific -20%, RoW -13%
- Thermo Fisher Scientific, Inc. (US)
- Agilent Technologies, Inc. (US)
- Merck KGaA (Germany)
- Danaher Corporation (US)
- PerkinElmer, Inc. (US)
- Tecan Group Ltd. (Switzerland)
- AXXAM S.p.A (Italy)
- Promega Corporation (US)
- Bio-Rad Laboratories, Inc.(US)
- Promega Corporation (US)
- Hamilton Company (US)
- Corning Incorporated (US)
- Charles River Laboratories (US)
- Lonza (Switzerland)
- REPROCELL Inc. (Japan)
- Aurora Biomed (Canada)
- BMG LABTECH (Germany)
- DIANA Biotechnologies, s.r.o. (Czech Republic)
- NanoTemper Technologies GmbH (Germany)
- Creative Biolabs (US)
- Biomat Srl (Italy)
This report provides a detailed picture of the Immunofluorescence assay market. It aims at estimating the size and future growth potential of the market across different segments, such as the product, type, disease, end user, and region. The report also includes an in-depth competitive analysis of the key market players, along with their company profiles, recent developments, and key market strategies.
Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall high-throughput screening market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, trends, opportunities, and challenges.
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS & EXCLUSIONS
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED IN THE REPORT
1.4 CURRENCY
1.5 STAKEHOLDERS
1.6 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
FIGURE 1 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
FIGURE 2 PRIMARY SOURCES
2.1.2.1 Key data from primary sources
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS
2.2 MARKET SIZE ESTIMATION
FIGURE 4 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
FIGURE 5 MARKET SIZE ESTIMATION: HIGH THROUGHPUT SCREENING MARKET
2.3 GROWTH RATE ASSUMPTIONS /GROWTH FORECAST
FIGURE 6 SEGMENTAL GROWTH RATE OF COMPANIES (2016?2019)
FIGURE 7 FINAL CAGR PROJECTIONS (2020?2025)
FIGURE 8 CAGR PROJECTIONS FROM THE ANALYSIS OF DEMAND-SIDE DRIVERS AND OPPORTUNITIES
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
FIGURE 9 DATA TRIANGULATION METHODOLOGY
2.5 MARKET SHARE ESTIMATION
2.6 ASSUMPTIONS FOR THE STUDY
3 EXECUTIVE SUMMARY
FIGURE 10 GLOBAL HTS MARKET, BY PRODUCT & SERVICE, 2020 VS. 2025 (USD BILLION)
FIGURE 11 GLOBAL HTS MARKET, BY TECHNOLOGY, 2020 VS. 2025 (USD BILLION)
FIGURE 12 GLOBAL HTS MARKET, BY APPLICATION, 2020 VS. 2025 (USD BILLION)
FIGURE 13 GLOBAL HTS MARKET, BY END USER, 2020 VS. 2025 (USD MILLION)
FIGURE 14 HTS MARKET: GEOGRAPHIC SNAPSHOT
4 PREMIUM INSIGHTS
4.1 HIGH-THROUGHPUT SCREENING MARKET OVERVIEW
FIGURE 15 INCREASING GOVERNMENT FUNDING FOR PHARMACEUTICAL R&D AND TECHNOLOGICAL ADVANCEMENTS IN THE HTS MARKET ARE KEY GROWTH DRIVERS
4.2 NORTH AMERICA: HIGH-THROUGHPUT SCREENING MARKET, MARKET SHARE (2019)
FIGURE 16 CONSUMABLES COMMANDED THE LARGEST SHARE OF THE NORTH AMERICAN HIGH-THROUGHPUT SCREENING MARKET IN 2019
4.3 HIGH-THROUGHPUT SCREENING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 17 CHINA TO WITNESS THE HIGHEST GROWTH RATE IN THE HTS MARKET DURING THE FORECAST PERIOD
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 18 HIGH-THROUGHPUT SCREENING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 MARKET DRIVERS
5.2.1.1 The growing adoption of open innovation models in pharmaceutical & biotechnology companies
5.2.1.2 Government funding and venture capital investments
5.2.1.3 Increasing R&D spending
TABLE 1 INCREASE IN COMPANY R&D EXPENDITURE (2018–2019)
5.2.1.4 Technological advancements in the HTS market
5.2.2 MARKET RESTRAINTS
5.2.2.1 The capital-intensive nature of HTS instruments
5.2.2.2 Complexities in assay development
5.2.3 MARKET OPPORTUNITIES
5.2.3.1 Emerging markets
5.2.3.2 Growing applications in stem cell research
5.2.4 MARKET CHALLENGES
5.2.4.1 The dearth of skilled operators
FIGURE 19 FUNCTIONAL AREAS WITH DIFFICULT TO FILL POSITIONS
5.3 IMPACT OF THE COVID-19 ON THE MARKET
5.3.1 COVID-19 VACCINE CANDIDATES: KEY DEVELOPMENTS
5.3.2 COVID-19 DRUG R&D: VACCINE PRODUCTION SCENARIO, BY COUNTRY
5.4 TECHNOLOGY ANALYSIS
5.4.1 LABEL-FREE TECHNOLOGY
5.4.2 AUTOMATION & MINIATURIZATION
5.4.3 MICROFLUIDICS
5.5 PRICING ANALYSIS
5.6 VALUE CHAIN ANALYSIS
FIGURE 20 MAJOR VALUE IS ADDED DURING THE MANUFACTURING AND
ASSEMBLY PHASE
5.7 SUPPLY CHAIN ANALYSIS
FIGURE 21 DIRECT DISTRIBUTION—STRATEGY PREFERRED BY PROMINENT COMPANIES
5.8 ECOSYSTEM ANALYSIS OF THE HTS MARKET
FIGURE 22 ECOSYSTEM ANALYSIS OF THE HTS MARKET
5.9 PORTER’S FIVE FORCES ANALYSIS
FIGURE 23 HIGH CAPITAL INVESTMENTS TO RESTRICT THE ENTRY OF NEW PLAYERS
5.9.1 THREAT OF NEW ENTRANTS
5.9.2 THREAT OF SUBSTITUTES
5.9.3 BARGAINING POWER OF BUYERS
5.9.4 BARGAINING POWER OF SUPPLIERS
5.9.5 INTENSITY OF COMPETITIVE RIVALRY
5.10 REGULATORY ANALYSIS
5.11 PATENT ANALYSIS
FIGURE 24 NO OF PATENT GRANTED FOR HIGH THROUGHPUT SCREENING METHOD DEVELOPMENT, JANUARY 2010 - DECEMBER 2020
6 HIGH-THROUGHPUT SCREENING MARKET, BY PRODUCT & SERVICE
6.1 INTRODUCTION
TABLE 2 HIGH-THROUGHPUT SCREENING MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
6.2 CONSUMABLES
TABLE 3 HTS CONSUMABLES MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 4 NORTH AMERICA: CONSUMABLES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 5 EUROPE: CONSUMABLES MARKET, BY COUNTRY/REGION, 2018–2025 (USD MILLION)
TABLE 6 ASIA PACIFIC: CONSUMABLES MARKET, BY COUNTRY/REGION, 2018–2025 (USD MILLION)
TABLE 7 ROW: CONSUMABLES MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 8 HTS CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION)
6.2.1 REAGENTS & ASSAY KITS
6.2.1.1 Reagents & assay kits accounted for the largest share of the consumables segment in 2019
TABLE 9 REAGENTS & ASSAY KITS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 10 NORTH AMERICA: REAGENTS & ASSAY KITS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 11 EUROPE: REAGENTS & ASSAY KITS MARKET, BY COUNTRY/REGION, 2018–2025 (USD MILLION)
TABLE 12 ASIA PACIFIC: REAGENTS & ASSAY KITS MARKET, BY COUNTRY/REGION, 2018–2025 (USD MILLION)
TABLE 13 ROW: REAGENTS & ASSAY KITS MARKET, BY REGION, 2018–2025 (USD MILLION)
6.2.2 LABORATORY EQUIPMENT
6.2.2.1 The development of high-quality equipment by market players will propel market growth
TABLE 14 LABORATORY EQUIPMENT MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 15 NORTH AMERICA: LABORATORY EQUIPMENT MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 16 EUROPE: LABORATORY EQUIPMENT MARKET, BY COUNTRY/REGION, 2018–2025 (USD MILLION)
TABLE 17 ASIA PACIFIC: LABORATORY EQUIPMENT MARKET, BY COUNTRY/REGION, 2018–2025 (USD MILLION)
TABLE 18 ROW: LABORATORY EQUIPMENT MARKET, BY REGION, 2018–2025 (USD MILLION)
6.3 INSTRUMENTS
TABLE 19 HTS INSTRUMENTS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 20 NORTH AMERICA: INSTRUMENTS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 21 EUROPE: INSTRUMENTS MARKET, BY COUNTRY/REGION, 2018–2025 (USD MILLION)
TABLE 22 ASIA PACIFIC: INSTRUMENTS MARKET, BY COUNTRY/REGION, 2018–2025 (USD MILLION)
TABLE 23 ROW: INSTRUMENTS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 24 HTS INSTRUMENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
6.3.1 LIQUID HANDLING SYSTEMS
6.3.1.1 The liquid handling systems segment is projected to witness the highest growth rate during the forecast period
TABLE 25 LIQUID HANDLING SYSTEMS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 26 NORTH AMERICA: LIQUID HANDLING SYSTEMS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 27 EUROPE: LIQUID HANDLING SYSTEMS MARKET, BY COUNTRY/REGION, 2018–2025 (USD MILLION)
TABLE 28 ASIA PACIFIC: LIQUID HANDLING SYSTEMS MARKET, BY COUNTRY/REGION, 2018–2025 (USD MILLION)
TABLE 29 ROW: LIQUID HANDLING SYSTEMS MARKET, BY REGION, 2018–2025 (USD MILLION)
6.3.2 DETECTION SYSTEMS
6.3.2.1 Growth in this segment can be attributed to technological advancements in automation
TABLE 30 DETECTION SYSTEMS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 31 NORTH AMERICA: DETECTION SYSTEMS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 32 EUROPE: DETECTION SYSTEMS MARKET, BY COUNTRY/REGION, 2018–2025 (USD MILLION)
TABLE 33 ASIA PACIFIC: DETECTION SYSTEMS MARKET, BY COUNTRY/REGION, 2018–2025 (USD MILLION)
TABLE 34 ROW: DETECTION SYSTEMS MARKET, BY REGION, 2018–2025 (USD MILLION)
6.3.3 OTHER INSTRUMENTS
TABLE 35 OTHER INSTRUMENTS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 36 NORTH AMERICA: OTHER INSTRUMENTS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 37 EUROPE: OTHER INSTRUMENTS MARKET, BY COUNTRY/REGION, 2018–2025 (USD MILLION)
TABLE 38 ASIA PACIFIC: OTHER INSTRUMENTS MARKET, BY COUNTRY/REGION, 2018–2025 (USD MILLION)
TABLE 39 ROW: OTHER INSTRUMENTS MARKET, BY REGION, 2018–2025 (USD MILLION)
6.4 SERVICES
6.4.1 THIS SEGMENT IS PROJECTED TO GROW AT THE HIGHEST CAGR DUE TO THE INCREASING OUTSOURCING OF R&D ACTIVITIES IN EMERGING MARKETS
TABLE 40 HTS SERVICES MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 41 NORTH AMERICA: SERVICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 42 EUROPE: SERVICES MARKET, BY COUNTRY/REGION, 2018–2025 (USD MILLION)
TABLE 43 ASIA PACIFIC: SERVICES MARKET, BY COUNTRY/REGION, 2018–2025 (USD MILLION)
TABLE 44 ROW: SERVICES MARKET, BY REGION, 2018–2025 (USD MILLION)
6.5 SOFTWARE
6.5.1 AUTOMATION IN HTS AND THE AVAILABILITY OF ROBUST DATA MANAGEMENT SOFTWARE TOOLS TO DRIVE MARKET GROWTH
TABLE 45 HTS SOFTWARE MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 46 NORTH AMERICA: SOFTWARE MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 47 EUROPE: SOFTWARE MARKET, BY COUNTRY/REGION, 2018–2025 (USD MILLION)
TABLE 48 ASIA PACIFIC: SOFTWARE MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 49 ROW: SOFTWARE MARKET, BY REGION, 2018–2025 (USD MILLION)
7 HIGH-THROUGHPUT SCREENING MARKET, BY TECHNOLOGY
7.1 INTRODUCTION
TABLE 50 HIGH-THROUGHPUT SCREENING MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
7.2 CELL-BASED ASSAYS
TABLE 51 HTS FOR CELL-BASED ASSAYS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 52 CELL-BASED ASSAYS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 53 NORTH AMERICA: CELL- BASED ASSAYS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 54 EUROPE: CELL-BASED ASSAYS MARKET, BY COUNTRY/REGION, 2018–2025 (USD MILLION)
TABLE 55 ASIA PACIFIC: CELL-BASED ASSAYS MARKET, BY COUNTRY/REGION, 2018–2025 (USD MILLION)
TABLE 56 ROW: CELL-BASED ASSAYS MARKET, BY REGION, 2018–2025 (USD MILLION)
7.2.1 2D CELL CULTURE
7.2.1.1 Market growth can be attributed to the cost-effectiveness of 2D cell culture systems
TABLE 57 2D CELL CULTURE MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 58 NORTH AMERICA: 2D CELL CULTURE MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 59 EUROPE: 2D CELL CULTURE MARKET, BY COUNTRY/REGION, 2018–2025 (USD MILLION)
TABLE 60 ASIA PACIFIC: 2D CELL CULTURE MARKET, BY COUNTRY/REGION, 2018–2025 (USD MILLION)
TABLE 61 ROW: 2D CELL CULTURE MARKET, BY REGION, 2018–2025 (USD MILLION)
7.2.2 3D CELL CULTURE
TABLE 62 3D CELL CULTURE MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 63 3D CELL CULTURE MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 64 NORTH AMERICA: 3D CELL CULTURE MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 65 EUROPE: 3D CELL CULTURE MARKET, BY COUNTRY/REGION, 2018–2025 (USD MILLION)
TABLE 66 ASIA PACIFIC: 3D CELL CULTURE MARKET, BY COUNTRY/REGION, 2018–2025 (USD MILLION)
TABLE 67 ROW: 3D CELL CULTURE MARKET, BY REGION, 2018–2025 (USD MILLION)
7.2.2.1 Scaffold-based technology
TABLE 68 SCAFFOLD-BASED TECHNOLOGY MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 69 SCAFFOLD-BASED TECHNOLOGY MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 70 NORTH AMERICA: SCAFFOLD-BASED TECHNOLOGY MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 71 EUROPE: SCAFFOLD-BASED TECHNOLOGY MARKET, BY COUNTRY/REGION, 2018–2025 (USD MILLION)
TABLE 72 ASIA PACIFIC: SCAFFOLD-BASED TECHNOLOGY MARKET, BY COUNTRY/REGION, 2018–2025 (USD MILLION)
TABLE 73 ROW: SCAFFOLD-BASED TECHNOLOGY MARKET, BY REGION, 2018–2025 (USD MILLION)
7.2.2.1.1 Hydrogels
TABLE 74 HYDROGELS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 75 HYDROGELS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 76 NORTH AMERICA: HYDROGELS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 77 EUROPE: HYDROGELS MARKET, BY COUNTRY/REGION, 2018–2025 (USD MILLION)
TABLE 78 ASIA PACIFIC: HYDROGELS MARKET, BY COUNTRY/REGION, 2018–2025 (USD MILLION)
TABLE 79 ROW: HYDROGELS MARKET, BY REGION, 2018–2025 (USD MILLION)
7.2.2.1.1.1 Animal-derived hydrogels
TABLE 80 ANIMAL-DERIVED HYDROGELS MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 81 ANIMAL-DERIVED HYDROGELS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 82 NORTH AMERICA: ANIMAL-DERIVED HYDROGELS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 83 EUROPE: ANIMAL-DERIVED HYDROGELS MARKET, BY COUNTRY/REGION, 2018–2025 (USD MILLION)
TABLE 84 ASIA PACIFIC: ANIMAL-DERIVED HYDROGELS MARKET, BY COUNTRY/REGION, 2018–2025 (USD MILLION)
TABLE 85 ROW: ANIMAL-DERIVED HYDROGELS MARKET, BY REGION, 2018–2025 (USD MILLION)
7.2.2.1.1.1.1 Matrigel
7.2.2.1.1.1.1.1 The Matrigel segment accounted for the largest share of the animal-derived hydrogels market in 2019
TABLE 86 MATRIGEL MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 87 NORTH AMERICA: MATRIGEL MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 88 EUROPE: MATRIGEL MARKET, BY COUNTRY/REGION, 2018–2025 (USD MILLION)
TABLE 89 ASIA PACIFIC: MATRIGEL MARKET, BY COUNTRY/REGION, 2018–2025 (USD MILLION)
TABLE 90 ROW: MATRIGEL MARKET, BY REGION, 2018–2025 (USD MILLION)
7.2.2.1.1.1.2 Collagen
TABLE 91 COLLAGEN MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 92 NORTH AMERICA: COLLAGEN MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 93 EUROPE: COLLAGEN MARKET, BY COUNTRY/REGION, 2018–2025 (USD MILLION)
TABLE 94 ASIA PACIFIC: COLLAGEN MARKET, BY COUNTRY/REGION, 2018–2025 (USD MILLION)
TABLE 95 ROW: COLLAGEN MARKET, BY REGION, 2018–2025 (USD MILLION)
7.2.2.1.1.2 Synthetic hydrogels
7.2.2.1.1.2.1 The long service life and high gel strength of synthetic hydrogels drive the market growth
TABLE 96 SYNTHETIC HYDROGELS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 97 NORTH AMERICA: SYNTHETIC HYDROGELS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 98 EUROPE: SYNTHETIC HYDROGELS MARKET, BY COUNTRY/REGION, 2018–2025 (USD MILLION)
TABLE 99 ASIA PACIFIC: SYNTHETIC HYDROGELS MARKET, BY COUNTRY/REGION, 2018–2025 (USD MILLION)
TABLE 100 ROW: SYNTHETIC HYDROGELS MARKET, BY REGION, 2018–2025 (USD MILLION)
7.2.2.1.1.3 Alginate/Agarose
7.2.2.1.1.3.1 This technique is used to culture cells in soft agar gels from plant sources like algae
TABLE 101 ALGINATE/AGAROSE MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 102 NORTH AMERICA: ALGINATE/AGAROSE MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 103 EUROPE: ALGINATE/AGAROSE MARKET, BY COUNTRY/REGION, 2018–2025 (USD MILLION)
TABLE 104 ASIA PACIFIC: ALGINATE/AGAROSE MARKET, BY COUNTRY/REGION, 2018–2025 (USD MILLION)
TABLE 105 ROW: ALGINATE/AGAROSE MARKET, BY REGION, 2018–2025 (USD MILLION)
7.2.2.1.2 Inert matrix/Solid scaffolds
7.2.2.1.2.1 This technique minimizes batch-to-batch variation and promotes better reproducibility & consistency to the cell culture
TABLE 106 INERT MATRIX/SOLID SCAFFOLDS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 107 NORTH AMERICA: INERT MATRIX/SOLID SCAFFOLDS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 108 EUROPE: INERT MATRIX/SOLID SCAFFOLDS MARKET, BY COUNTRY/REGION, 2018–2025 (USD MILLION)
TABLE 109 ASIA PACIFIC: INERT MATRIX/SOLID SCAFFOLDS MARKET, BY COUNTRY/REGION, 2018–2025 (USD MILLION)
TABLE 110 ROW: INERT MATRIX/SOLID SCAFFOLDS MARKET, BY REGION, 2018–2025 (USD MILLION)
7.2.2.1.3 Micropatterned surfaces
7.2.2.1.3.1 Micropatterned surfaces enhance the expression of enzymes levels and drug reactivity in cell cultures
TABLE 111 MICROPATTERNED SURFACES MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 112 NORTH AMERICA: MICROPATTERNED SURFACES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 113 EUROPE: MICROPATTERNED SURFACES MARKET, BY COUNTRY/REGION, 2018–2025 (USD MILLION)
TABLE 114 ASIA PACIFIC: MICROPATTERNED SURFACES MARKET, BY COUNTRY/REGION, 2018–2025 (USD MILLION)
TABLE 115 ROW: MICROPATTERNED SURFACES MARKET, BY REGION, 2018–2025 (USD MILLION)
7.2.2.2 Scaffold-free technology
TABLE 116 SCAFFOLD-FREE TECHNOLOGY MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 117 SCAFFOLD-FREE TECHNOLOGY MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 118 NORTH AMERICA: SCAFFOLD-FREE TECHNOLOGY MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 119 EUROPE: SCAFFOLD-FREE TECHNOLOGY MARKET, BY COUNTRY/REGION, 2018–2025 (USD MILLION)
TABLE 120 ASIA PACIFIC: SCAFFOLD-FREE TECHNOLOGY MARKET, BY COUNTRY/REGION, 2018–2025 (USD MILLION)
TABLE 121 ROW: SCAFFOLD-FREE TECHNOLOGY MARKET, BY REGION, 2018–2025 (USD MILLION)
7.2.2.2.1 Ultra-low binding plates
7.2.2.2.1.1 This segment accounted for the largest share of the scaffold-free technology market in 2019
TABLE 122 ULTRA-LOW BINDING PLATES MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 123 NORTH AMERICA: ULTRA-LOW BINDING PLATES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 124 EUROPE: ULTRA-LOW BINDING PLATES MARKET, BY COUNTRY/REGION, 2018–2025 (USD MILLION)
TABLE 125 ASIA PACIFIC: ULTRA-LOW BINDING PLATES MARKET, BY COUNTRY/REGION, 2018–2025 (USD MILLION)
TABLE 126 ROW: ULTRA-LOW BINDING PLATES MARKET, BY REGION, 2018–2025 (USD MILLION)
7.2.2.2.2 Hanging-drop plates
7.2.2.2.2.1 The cost-effectiveness of hanging-drop plates over other methods for 3D cell culture drives the market growth
TABLE 127 HANGING-DROP PLATES MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 128 NORTH AMERICA: HANGING-DROP PLATES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 129 EUROPE: HANGING-DROP PLATES MARKET, BY COUNTRY/REGION, 2018–2025 (USD MILLION)
TABLE 130 ASIA PACIFIC: HANGING-DROP PLATES MARKET, BY COUNTRY/REGION, 2018–2025 (USD MILLION)
TABLE 131 ROW: HANGING-DROP PLATES MARKET, BY REGION, 2018–2025 (USD MILLION)
7.2.2.2.3 Other scaffold-free technologies
TABLE 132 OTHER SCAFFOLD-FREE TECHNOLOGIES MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 133 NORTH AMERICA: OTHER SCAFFOLD-FREE TECHNOLOGIES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 134 EUROPE: OTHER SCAFFOLD-FREE TECHNOLOGIES MARKET, BY COUNTRY/REGION, 2018–2025 (USD MILLION)
TABLE 135 ASIA PACIFIC: OTHER SCAFFOLD-FREE TECHNOLOGIES MARKET, BY COUNTRY/REGION, 2018–2025 (USD MILLION)
TABLE 136 ROW: OTHER SCAFFOLD-FREE TECHNOLOGIES MARKET, BY REGION, 2018–2025 (USD MILLION)
7.2.3 REPORTER-BASED ASSAYS
7.2.3.1 Growing applications of gene expression will support the market growth of this segment
TABLE 137 REPORTER-BASED ASSAYS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 138 NORTH AMERICA: REPORTER-BASED ASSAYS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 139 EUROPE: REPORTER-BASED ASSAYS MARKET, BY COUNTRY/REGION, 2018–2025 (USD MILLION)
TABLE 140 ASIA PACIFIC: REPORTER-BASED ASSAYS MARKET, BY COUNTRY/REGION, 2018–2025 (USD MILLION)
TABLE 141 ROW: REPORTER-BASED ASSAYS MARKET, BY REGION, 2018–2025 (USD MILLION)
7.2.4 PERFUSION CELL CULTURE
7.2.4.1 Perfusion cell culture provides higher product output as compared to traditional techniques
TABLE 142 PERFUSION CELL CULTURE MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 143 NORTH AMERICA: PERFUSION CELL CULTURE MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 144 EUROPE: PERFUSION CELL CULTURE MARKET, BY COUNTRY/REGION, 2018–2025 (USD MILLION)
TABLE 145 ASIA PACIFIC: PERFUSION CELL CULTURE MARKET, BY COUNTRY/REGION, 2018–2025 (USD MILLION)
TABLE 146 ROW: PERFUSION CELL CULTURE MARKET, BY REGION, 2018–2025 (USD MILLION)
7.3 LAB-ON-A-CHIP TECHNOLOGY (LOC)
7.3.1 MARKET GROWTH CAN BE ATTRIBUTED TO COST-EFFECTIVENESS OF THE TECHNIQUE OWING TO THE LOW CONSUMPTION OF REAGENTS
TABLE 147 HTS FOR LAB-ON-A-CHIP TECHNOLOGY MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 148 NORTH AMERICA: LAB-ON-A-CHIP TECHNOLOGY MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 149 EUROPE: LAB-ON-A-CHIP TECHNOLOGY MARKET, BY COUNTRY/REGION, 2018–2025 (USD MILLION)
TABLE 150 ASIA PACIFIC: LAB-ON-A-CHIP TECHNOLOGY MARKET, BY COUNTRY/REGION, 2018–2025 (USD MILLION)
TABLE 151 ROW: LAB-ON-A-CHIP TECHNOLOGY MARKET, BY REGION, 2018–2025 (USD MILLION)
7.4 LABEL-FREE TECHNOLOGY
7.4.1 LABEL-FREE TECHNOLOGY ENABLES THE INVESTIGATION OF BIOMOLECULAR INTERACTIONS WITHOUT THE EFFECTS OF LABELS
TABLE 152 HTS FOR LABEL-FREE TECHNOLOGY MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 153 NORTH AMERICA: LABEL-FREE TECHNOLOGY MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 154 EUROPE: LABEL-FREE TECHNOLOGY, BY COUNTRY/REGION, 2018–2025 (USD MILLION)
TABLE 155 ASIA PACIFIC: LABEL-FREE TECHNOLOGY, BY COUNTRY/REGION, 2018–2025 (USD MILLION)
TABLE 156 ROW: LABEL-FREE TECHNOLOGY, BY REGION, 2018–2025 (USD MILLION)
8 HIGH-THROUGHPUT SCREENING MARKET, BY APPLICATION
8.1 INTRODUCTION
TABLE 157 GLOBAL HIGH-THROUGHPUT SCREENING MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
8.2 DRUG DISCOVERY
8.2.1 INCREASING DEMAND FOR DRUGS IN THE TREATMENT OF VARIOUS DISEASES TO DRIVE MARKET GROWTH
TABLE 158 DRUG DISCOVERY MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 159 NORTH AMERICA: DRUG DISCOVERY MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 160 EUROPE: DRUG DISCOVERY MARKET, BY COUNTRY/REGION, 2018–2025 (USD MILLION)
TABLE 161 ASIA PACIFIC: DRUG DISCOVERY MARKET, BY COUNTRY/REGION, 2018–2025 (USD MILLION)
TABLE 162 ROW: DRUG DISCOVERY MARKET, BY REGION, 2018–2025 (USD MILLION)
8.3 BIOCHEMICAL SCREENING
8.3.1 THE INCREASING AWARENESS OF GENETIC DISORDERS AND SCREENING TESTS TO DRIVE MARKET GROWTH
TABLE 163 BIOCHEMICAL SCREENING MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 164 NORTH AMERICA: BIOCHEMICAL SCREENING MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 165 EUROPE: BIOCHEMICAL SCREENING MARKET, BY COUNTRY/REGION, 2018–2025 (USD MILLION)
TABLE 166 ASIA PACIFIC: BIOCHEMICAL SCREENING MARKET, BY COUNTRY/REGION, 2018–2025 (USD MILLION)
TABLE 167 ROW: BIOCHEMICAL SCREENING MARKET, BY REGION, 2018–2025 (USD MILLION)
8.4 LIFE SCIENCES RESEARCH
8.4.1 INCREASING INVESTMENTS IN STEM CELL RESEARCH & THE STUDY OF INFECTIOUS DISEASES TO CONTRIBUTE TO MARKET GROWTH
TABLE 168 LIFE SCIENCES RESEARCH MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 169 NORTH AMERICA: LIFE SCIENCES RESEARCH MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 170 EUROPE: LIFE SCIENCES RESEARCH MARKET, BY COUNTRY/REGION, 2018–2025 (USD MILLION)
TABLE 171 ASIA PACIFIC: LIFE SCIENCES RESEARCH MARKET, BY COUNTRY/REGION, 2018–2025 (USD MILLION)
TABLE 172 ROW: LIFE SCIENCES RESEARCH MARKET, BY REGION, 2018–2025 (USD MILLION)
8.5 OTHER APPLICATIONS
TABLE 173 OTHER APPLICATIONS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 174 NORTH AMERICA: OTHER APPLICATIONS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 175 EUROPE: OTHER APPLICATIONS MARKET, BY COUNTRY/REGION, 2018–2025 (USD MILLION)
TABLE 176 ASIA PACIFIC: OTHER APPLICATIONS MARKET, BY COUNTRY/REGION, 2018–2025 (USD MILLION)
TABLE 177 ROW: OTHER APPLICATIONS MARKET, BY REGION, 2018–2025 (USD MILLION)
9 HIGH-THROUGHPUT SCREENING MARKET, BY END USER
9.1 INTRODUCTION
TABLE 178 HIGH-THROUGHPUT SCREENING MARKET, BY END USER, 2018–2025 (USD MILLION)
9.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
9.2.1 RISING R&D SPENDING BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO SUPPORT MARKET GROWTH
TABLE 179 HTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2025 (USD MILLION)
TABLE 180 NORTH AMERICA: HTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018-2025 (USD MILLION)
TABLE 181 EUROPE: HTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY/REGION, 2018-2025 (USD MILLION)
TABLE 182 ASIA PACIFIC: HTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY/REGION, 2018-2025 (USD MILLION)
TABLE 183 ROW: HTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2025 (USD MILLION)
9.3 ACADEMIC & RESEARCH INSTITUTES
9.3.1 COLLABORATIONS BETWEEN PHARMACEUTICAL COMPANIES AND RESEARCHERS TO CONTRIBUTE TO THE GROWTH OF THIS MARKET
TABLE 184 HTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018–2025 (USD MILLION)
TABLE 185 NORTH AMERICA: HTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2018-2025 (USD MILLION)
TABLE 186 EUROPE: HTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY/REGION, 2018-2025 (USD MILLION)
TABLE 187 ASIA PACIFIC: HTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY/REGION, 2018-2025 (USD MILLION)
TABLE 188 ROW: HTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2025 (USD MILLION)
9.4 CONTRACT RESEARCH ORGANIZATIONS (CROS)
9.4.1 INCREASING OUTSOURCING OF R&D ACTIVITIES TO DRIVE MARKET GROWTH FOR CROS
TABLE 189 HTS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018–2025 (USD MILLION)
TABLE 190 NORTH AMERICA: HTS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018-2025 (USD MILLION)
TABLE 191 EUROPE: HTS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY/REGION, 2018-2025 (USD MILLION)
TABLE 192 ASIA PACIFIC: HTS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY/REGION, 2018-2025 (USD MILLION)
TABLE 193 ROW: HTS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2025 (USD MILLION)
9.5 OTHER END USERS
TABLE 194 HTS MARKET FOR OTHER END USERS, BY REGION, 2018–2025 (USD MILLION)
TABLE 195 NORTH AMERICA: HTS MARKET FOR OTHER END USERS, BY COUNTRY, 2018-2025 (USD MILLION)
TABLE 196 EUROPE: HTS MARKET FOR OTHER END USERS, BY COUNTRY/REGION, 2018-2025 (USD MILLION)
TABLE 197 ASIA PACIFIC: HTS MARKET FOR OTHER END USERS, BY COUNTRY/REGION, 2018-2025 (USD MILLION)
TABLE 198 ROW: HTS MARKET FOR OTHER END USERS, BY REGION, 2018-2025 (USD MILLION)
10 HIGH-THROUGHPUT SCREENING MARKET, BY REGION
10.1 INTRODUCTION
TABLE 199 HTS MARKET, BY REGION, 2018–2025 (USD MILLION)
10.2 NORTH AMERICA
FIGURE 25 NORTH AMERICA: HIGH-THROUGHPUT SCREENING MARKET SNAPSHOT
TABLE 200 NORTH AMERICA: HTS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 201 NORTH AMERICA: HTS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 202 NORTH AMERICA: CELL-BASED ASSAYS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 203 NORTH AMERICA: 3D CELL CULTURE MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 204 NORTH AMERICA: SCAFFOLD-BASED TECHNOLOGIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 205 NORTH AMERICA: HYDROGELS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 206 NORTH AMERICA: ANIMAL-DERIVED HYDROGELS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 207 NORTH AMERICA: SCAFFOLD-FREE TECHNOLOGIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 208 NORTH AMERICA: HTS MARKET, BY PRODUCT AND SERVICE, 2018–2025 (USD MILLION)
TABLE 209 NORTH AMERICA: CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 210 NORTH AMERICA: INSTRUMENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 211 NORTH AMERICA: HTS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 212 NORTH AMERICA: HTS MARKET, BY END USER, 2018–2025 (USD MILLION)
10.2.1 US
10.2.1.1 Market growth is attributed to rising government funding for research activities in the US
TABLE 213 NIH BUDGET FOR VARIOUS DISCIPLINES IN 2019 AND 2020
TABLE 214 US: HTS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 215 US: CELL-BASED ASSAYS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 216 US: 3D CELL CULTURE MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 217 US: SCAFFOLD-BASED TECHNOLOGIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 218 US: HYDROGELS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 219 US: ANIMAL-DERIVED HYDROGELS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 220 US: SCAFFOLD-FREE TECHNOLOGIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 221 US: HTS MARKET, BY PRODUCT AND SERVICE, 2018–2025 (USD MILLION)
TABLE 222 US: CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 223 US: INSTRUMENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 224 US: HTS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 225 US: HTS MARKET, BY END USER, 2018–2025 (USD MILLION)
10.2.2 CANADA
10.2.2.1 Government funding to promote drug discovery will support market growth in Canada
TABLE 226 CANADA: HTS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 227 CANADA: CELL-BASED ASSAYS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 228 CANADA: 3D CELL CULTURE MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 229 CANADA: SCAFFOLD-BASED TECHNOLOGIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 230 CANADA: HYDROGELS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 231 CANADA: ANIMAL-DERIVED HYDROGELS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 232 CANADA: SCAFFOLD-FREE TECHNOLOGIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 233 CANADA: HTS MARKET, BY PRODUCT AND SERVICE, 2018–2025 (USD MILLION)
TABLE 234 CANADA: CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 235 CANADA: INSTRUMENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 236 CANADA: HTS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 237 CANADA: HTS MARKET, BY END USER, 2018–2025 (USD MILLION)
10.2.3 EUROPE
TABLE 238 EUROPE: HTS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 239 EUROPE: HTS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 240 EUROPE: CELL-BASED ASSAYS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 241 EUROPE: 3D CELL CULTURE MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 242 EUROPE: SCAFFOLD-BASED TECHNOLOGIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 243 EUROPE: HYDROGELS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 244 EUROPE: ANIMAL-DERIVED HYDROGELS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 245 EUROPE: SCAFFOLD-FREE TECHNOLOGIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 246 EUROPE: HTS MARKET, BY PRODUCT AND SERVICE, 2018–2025 (USD MILLION)
TABLE 247 EUROPE: CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 248 EUROPE: INSTRUMENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 249 EUROPE: HTS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 250 EUROPE: HTS MARKET, BY END USER, 2018–2025 (USD MILLION)
10.2.4 GERMANY
10.2.4.1 Increasing research activities for HTS to drive market growth in Germany
TABLE 251 GERMANY: HTS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 252 GERMANY: CELL-BASED ASSAYS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 253 GERMANY: 3D CELL CULTURE MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 254 GERMANY: SCAFFOLD-BASED TECHNOLOGIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 255 GERMANY: HYDROGELS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 256 GERMANY: ANIMAL-DERIVED HYDROGELS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 257 GERMANY: SCAFFOLD-FREE TECHNOLOGIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 258 GERMANY: HTS MARKET, BY PRODUCT AND SERVICE, 2018–2025 (USD MILLION)
TABLE 259 GERMANY: CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 260 GERMANY: INSTRUMENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 261 GERMANY: HTS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 262 GERMANY: HTS MARKET, BY END USER, 2018–2025 (USD MILLION)
10.2.5 UK
10.2.5.1 Government funding for the domestic production of pharmaceutical products to drive market growth in the UK
TABLE 263 UK: HTS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 264 UK: CELL-BASED ASSAYS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 265 UK: 3D CELL CULTURE MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 266 UK: SCAFFOLD-BASED TECHNOLOGIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 267 UK: HYDROGELS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 268 UK: ANIMAL-DERIVED HYDROGELS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 269 UK: SCAFFOLD-FREE TECHNOLOGIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 270 UK: HTS MARKET, BY PRODUCT AND SERVICE, 2018–2025 (USD MILLION)
TABLE 271 UK: CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 272 UK: INSTRUMENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 273 UK: HTS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 274 UK: HTS MARKET, BY END USER, 2018–2025 (USD MILLION)
10.2.6 FRANCE
10.2.6.1 The growing pharmaceutical industry in France will support market growth for HTS technologies
TABLE 275 FRANCE: HTS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 276 FRANCE: CELL-BASED ASSAYS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 277 FRANCE: 3D CELL CULTURE MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 278 FRANCE: SCAFFOLD-BASED TECHNOLOGIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 279 FRANCE: HYDROGELS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 280 FRANCE: ANIMAL-DERIVED HYDROGELS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 281 FRANCE: SCAFFOLD-FREE TECHNOLOGIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 282 FRANCE: HTS MARKET, BY PRODUCT AND SERVICE, 2018–2025 (USD MILLION)
TABLE 283 FRANCE: CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 284 FRANCE: INSTRUMENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 285 FRANCE: HTS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 286 FRANCE: HTS MARKET, BY END USER, 2018–2025 (USD MILLION)
10.2.7 ITALY
10.2.7.1 Growing industry-academia collaborations to drive market growth in Italy
TABLE 287 ITALY: HTS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 288 ITALY: CELL-BASED ASSAYS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 289 ITALY: 3D CELL CULTURE MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 290 ITALY: SCAFFOLD-BASED TECHNOLOGIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 291 ITALY: HYDROGELS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 292 ITALY: ANIMAL-DERIVED HYDROGELS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 293 ITALY: SCAFFOLD-FREE TECHNOLOGIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 294 ITALY: HTS MARKET, BY PRODUCT AND SERVICE, 2018–2025 (USD MILLION)
TABLE 295 ITALY: CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 296 ITALY: INSTRUMENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 297 ITALY: HTS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 298 ITALY: HTS MARKET, BY END USER, 2018–2025 (USD MILLION)
10.2.8 SPAIN
10.2.8.1 A nationwide research network supported by funding for various programs will drive market growth in Spain
TABLE 299 SPAIN: HTS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 300 SPAIN: CELL-BASED ASSAYS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 301 SPAIN: 3D CELL CULTURE MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 302 SPAIN: SCAFFOLD-BASED TECHNOLOGIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 303 SPAIN: HYDROGELS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 304 SPAIN: ANIMAL-DERIVED HYDROGELS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 305 SPAIN: SCAFFOLD-FREE TECHNOLOGIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 306 SPAIN: HTS MARKET, BY PRODUCT AND SERVICE, 2018–2025 (USD MILLION)
TABLE 307 SPAIN: CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 308 SPAIN: INSTRUMENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 309 SPAIN: HTS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 310 SPAIN: HTS MARKET, BY END USER, 2018–2025 (USD MILLION)
10.2.9 REST OF EUROPE
TABLE 311 ROE: HTS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 312 ROE: CELL-BASED ASSAYS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 313 ROE: 3D CELL CULTURE MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 314 ROE: SCAFFOLD-BASED TECHNOLOGIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 315 ROE: HYDROGELS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 316 ROE: ANIMAL-DERIVED HYDROGELS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 317 ROE: SCAFFOLD-FREE TECHNOLOGIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 318 ROE: HTS MARKET, BY PRODUCT AND SERVICE, 2018–2025 (USD MILLION)
TABLE 319 ROE: CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 320 ROE: INSTRUMENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 321 ROE: HTS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 322 ROE: HTS MARKET, BY END USER, 2018–2025 (USD MILLION)
10.3 ASIA PACIFIC
FIGURE 26 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING MARKET SNAPSHOT
TABLE 323 ASIA PACIFIC: HTS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 324 ASIA PACIFIC: HTS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 325 ASIA PACIFIC: CELL-BASED ASSAYS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 326 ASIA PACIFIC: 3D CELL CULTURE MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 327 ASIA PACIFIC: SCAFFOLD-BASED TECHNOLOGIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 328 ASIA PACIFIC: HYDROGELS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 329 ASIA PACIFIC: ANIMAL-DERIVED HYDROGELS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 330 ASIA PACIFIC: SCAFFOLD-FREE TECHNOLOGIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 331 ASIA PACIFIC: HTS MARKET, BY PRODUCT AND SERVICE, 2018–2025 (USD MILLION)
TABLE 332 ASIA PACIFIC: CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 333 ASIA PACIFIC: INSTRUMENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 334 ASIA PACIFIC: HTS MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 335 ASIA PACIFIC: HTS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
10.3.1 CHINA
10.3.1.1 The rising number of CROs in China supports market growth for HTS
TABLE 336 CHINA: HTS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 337 CHINA: CELL-BASED ASSAYS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 338 CHINA: 3D CELL CULTURE MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 339 CHINA: SCAFFOLD-BASED TECHNOLOGIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 340 CHINA: HYDROGELS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 341 CHINA: ANIMAL-DERIVED HYDROGELS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 342 CHINA: SCAFFOLD-FREE TECHNOLOGIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 343 CHINA: HTS MARKET, BY PRODUCT AND SERVICE, 2018–2025 (USD MILLION)
TABLE 344 CHINA: CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 345 CHINA: INSTRUMENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 346 CHINA: HTS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 347 CHINA: HTS MARKET, BY END USER, 2018–2025 (USD MILLION)
10.3.2 JAPAN
10.3.2.1 High R&D expenditure by pharmaceutical companies to drive market growth in Japan
TABLE 348 JAPAN: HTS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 349 JAPAN: CELL-BASED ASSAYS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 350 JAPAN: 3D CELL CULTURE MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 351 JAPAN: SCAFFOLD-BASED TECHNOLOGIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 352 JAPAN: HYDROGELS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 353 JAPAN: ANIMAL-DERIVED HYDROGELS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 354 JAPAN: SCAFFOLD-FREE TECHNOLOGIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 355 JAPAN: HTS MARKET, BY PRODUCT AND SERVICE, 2018–2025 (USD MILLION)
TABLE 356 JAPAN: CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 357 JAPAN: INSTRUMENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 358 JAPAN: HTS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 359 JAPAN: HTS MARKET, BY END USER, 2018–2025 (USD MILLION)
10.3.3 INDIA
10.3.3.1 Market growth can be attributed to increasing government funding for the Indian pharmaceutical industry
TABLE 360 INDIA: HTS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 361 INDIA: CELL-BASED ASSAYS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 362 INDIA: 3D CELL CULTURE MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 363 INDIA: SCAFFOLD-BASED TECHNOLOGIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 364 INDIA: HYDROGELS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 365 INDIA: ANIMAL-DERIVED HYDROGELS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 366 INDIA: SCAFFOLD-FREE TECHNOLOGIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 367 INDIA: HTS MARKET, BY PRODUCT AND SERVICE, 2018–2025 (USD MILLION)
TABLE 368 INDIA: CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 369 INDIA: INSTRUMENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 370 INDIA: HTS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 371 INDIA: HTS MARKET, BY END USER, 2018–2025 (USD MILLION)
10.3.4 AUSTRALIA
10.3.4.1 Collaborations between research centers and pharmaceutical companies for drug discovery will drive market growth in Australia
TABLE 372 AUSTRALIA: HTS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 373 AUSTRALIA: CELL-BASED ASSAYS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 374 AUSTRALIA: 3D CELL CULTURE MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 375 AUSTRALIA: SCAFFOLD-BASED TECHNOLOGIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 376 AUSTRALIA: HYDROGELS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 377 AUSTRALIA: ANIMAL-DERIVED HYDROGELS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 378 AUSTRALIA: SCAFFOLD-FREE TECHNOLOGIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 379 AUSTRALIA: HTS MARKET, BY PRODUCT AND SERVICE, 2018–2025 (USD MILLION)
TABLE 380 AUSTRALIA: CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 381 AUSTRALIA: INSTRUMENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 382 AUSTRALIA: HTS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 383 AUSTRALIA: HTS MARKET. BY END USER, 2018–2025 (USD MILLION)
10.3.5 REST OF THE ASIA PACIFIC (ROAPAC)
TABLE 384 ROAPAC: HTS MARKET. BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 385 ROAPAC: CELL-BASED ASSAYS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 386 ROAPAC: 3D CELL CULTURE MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 387 ROAPAC: SCAFFOLD-BASED TECHNOLOGIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 388 ROAPAC: HYDROGELS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 389 ROAPAC: ANIMAL-DERIVED HYDROGELS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 390 ROAPAC: SCAFFOLD-FREE TECHNOLOGIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 391 ROAPAC: HTS MARKET. BY PRODUCT AND SERVICE, 2018–2025 (USD MILLION)
TABLE 392 ROAPAC: CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 393 ROAPAC: INSTRUMENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 394 ROAPAC: HTS MARKET. BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 395 ROAPAC: HTS MARKET. BY END USER, 2018–2025 (USD MILLION)
10.4 REST OF THE WORLD (ROW)
TABLE 396 ROW: HTS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 397 ROW: HTS MARKET. BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 398 ROW: CELL-BASED ASSAYS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 399 ROW: 3D CELL CULTURE MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 400 ROW: SCAFFOLD-BASED TECHNOLOGIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 401 ROW: HYDROGELS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 402 ROW: ANIMAL-DERIVED HYDROGELS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 403 ROW: SCAFFOLD-FREE TECHNOLOGIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 404 ROW: HTS MARKET. BY PRODUCT AND SERVICE, 2018–2025 (USD MILLION)
TABLE 405 ROW: CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 406 ROW: INSTRUMENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 407 ROW: HTS MARKET. BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 408 ROW: HTS MARKET. BY END USER, 2018–2025 (USD MILLION)
10.4.1 LATIN AMERICA
10.4.1.1 The emerging pharmaceutical industry in Latin America will drive market growth for HTS
TABLE 409 LATIN AMERICA: HTS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 410 LATIN AMERICA: CELL-BASED ASSAYS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 411 LATIN AMERICA: 3D CELL CULTURE MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 412 LATIN AMERICA: SCAFFOLD-BASED TECHNOLOGIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 413 LATIN AMERICA: HYDROGELS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 414 LATIN AMERICA: ANIMAL-DERIVED HYDROGELS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 415 LATIN AMERICA: SCAFFOLD-FREE TECHNOLOGIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 416 LATIN AMERICA: HTS MARKET, BY PRODUCT AND SERVICE, 2018–2025 (USD MILLION)
TABLE 417 LATIN AMERICA: CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 418 LATIN AMERICA: INSTRUMENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 419 LATIN AMERICA: HTS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 420 LATIN AMERICA: HTS MARKET, BY END USER, 2018–2025 (USD MILLION)
10.4.2 MIDDLE EAST AND AFRICA
10.4.2.1 Market growth can be attributed to changing demographics and favorable government policies for pharmaceutical R&D
TABLE 421 MIDDLE EAST AND AFRICA: HTS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 422 MIDDLE EAST AND AFRICA: CELL-BASED ASSAYS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 423 MIDDLE EAST AND AFRICA: 3D CELL CULTURE MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 424 MIDDLE EAST AND AFRICA: SCAFFOLD-BASED TECHNOLOGIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 425 MIDDLE EAST AND AFRICA: HYDROGELS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 426 MIDDLE EAST AND AFRICA: ANIMAL-DERIVED HYDROGELS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 427 MIDDLE EAST AND AFRICA: SCAFFOLD-FREE TECHNOLOGIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 428 MIDDLE EAST AND AFRICA: HTS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 429 MIDDLE EAST AND AFRICA: HTS MARKET, BY PRODUCT AND SERVICE, 2018–2025 (USD MILLION)
TABLE 430 MIDDLE EAST AND AFRICA: CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 431 MIDDLE EAST AND AFRICA: INSTRUMENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 432 MIDDLE EAST AND AFRICA: HTS MARKET, BY END USER, 2018–2025 (USD MILLION)
11 COMPETITIVE LANDSCAPE
11.1 OVERVIEW
FIGURE 27 MARKET EVALUATION FRAMEWORK
11.2 REVENUE ANALYSIS OF TOP MARKET PLAYERS
TABLE 433 MARKET SHARE ANALYSIS: 2019
11.3 HIGH-THROUGHPUT SCREENING MARKET: COMPANY EVALUATION QUADRANT, 2019
11.3.1 STARS
11.3.2 EMERGING LEADERS
11.3.3 PERVASIVE COMPANIES
11.3.4 EMERGING COMPANIES
FIGURE 28 HIGH-THROUGHPUT SCREENING MARKET: COMPANY EVALUATION MATRIX, 2019
11.4 HIGH-THROUGHPUT SCREENING MARKET: START-UP/SME EVALUATION MATRIX, 2019
11.4.1 PROGRESSIVE COMPANIES
11.4.2 STARTING BLOCKS
11.4.3 RESPONSIVE COMPANIES
11.4.4 DYNAMIC COMPANIES
FIGURE 29 HIGH-THROUGHPUT SCREENING MARKET: STARTUP/SME EVALUATION MATRIX, 2019
11.5 KEY MARKET DEVELOPMENTS
11.5.1 KEY PRODUCT LAUNCHES
11.5.2 KEY ACQUISITIONS
11.5.3 KEY ALLIANCES, AGREEMENTS, AND COLLABORATIONS
11.5.4 KEY EXPANSIONS
12 COMPANY PROFILES
(Business Overview, Products Offered, Recent Developments, MnM View)*
12.1 THERMO FISHER SCIENTIFIC INC.
FIGURE 30 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2019)
12.2 AGILENT TECHNOLOGIES, INC.
FIGURE 31 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2019)
12.3 MERCK KGAA
FIGURE 32 MERCK KGAA: COMPANY SNAPSHOT (2019)
12.4 DANAHER CORPORATION
FIGURE 33 DANAHER CORPORATION: COMPANY SNAPSHOT (2019)
12.5 PERKINELMER, INC.
FIGURE 34 PERKINELMER, INC.: COMPANY SNAPSHOT (2019)
12.6 TECAN GROUP LTD.
FIGURE 35 TECAN GROUP LTD.: COMPANY SNAPSHOT (2019)
12.7 AXXAM S.P.A.
12.8 BIO-RAD LABORATORIES, INC.
FIGURE 36 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2019)
12.9 PROMEGA CORPORATION
12.10 CORNING INCORPORATED
FIGURE 37 CORNING INCORPORATED: COMPANY SNAPSHOT (2019)
12.11 CHARLES RIVER LABORATORIES
FIGURE 38 CHARLES RIVER LABORATORIES: COMPANY SNAPSHOT (2019)
12.12 EUROFINS SCIENTIFIC
FIGURE 39 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2019)
12.13 HAMILTON COMPANY
12.14 LONZA
FIGURE 40 LONZA: COMPANY SNAPSHOT (2020)
12.15 REPROCELL INC.
12.16 AURORA BIOMED
12.17 BMG LABTECH
12.18 DIANA BIOTECHNOLOGIES S.R.O.
12.19 NANOTEMPER TECHNOLOGIES GMBH
12.20 CREATIVE BIOLABS
12.21 BIOMAT SRL
*Business Overview, Products Offered, Recent Developments, MnM View might not be captured in case of unlisted companies.
13 APPENDIX
13.1 DISCUSSION GUIDE
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.3 AVAILABLE CUSTOMIZATIONS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS & EXCLUSIONS
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED IN THE REPORT
1.4 CURRENCY
1.5 STAKEHOLDERS
1.6 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
FIGURE 1 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
FIGURE 2 PRIMARY SOURCES
2.1.2.1 Key data from primary sources
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS
2.2 MARKET SIZE ESTIMATION
FIGURE 4 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
FIGURE 5 MARKET SIZE ESTIMATION: HIGH THROUGHPUT SCREENING MARKET
2.3 GROWTH RATE ASSUMPTIONS /GROWTH FORECAST
FIGURE 6 SEGMENTAL GROWTH RATE OF COMPANIES (2016?2019)
FIGURE 7 FINAL CAGR PROJECTIONS (2020?2025)
FIGURE 8 CAGR PROJECTIONS FROM THE ANALYSIS OF DEMAND-SIDE DRIVERS AND OPPORTUNITIES
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
FIGURE 9 DATA TRIANGULATION METHODOLOGY
2.5 MARKET SHARE ESTIMATION
2.6 ASSUMPTIONS FOR THE STUDY
3 EXECUTIVE SUMMARY
FIGURE 10 GLOBAL HTS MARKET, BY PRODUCT & SERVICE, 2020 VS. 2025 (USD BILLION)
FIGURE 11 GLOBAL HTS MARKET, BY TECHNOLOGY, 2020 VS. 2025 (USD BILLION)
FIGURE 12 GLOBAL HTS MARKET, BY APPLICATION, 2020 VS. 2025 (USD BILLION)
FIGURE 13 GLOBAL HTS MARKET, BY END USER, 2020 VS. 2025 (USD MILLION)
FIGURE 14 HTS MARKET: GEOGRAPHIC SNAPSHOT
4 PREMIUM INSIGHTS
4.1 HIGH-THROUGHPUT SCREENING MARKET OVERVIEW
FIGURE 15 INCREASING GOVERNMENT FUNDING FOR PHARMACEUTICAL R&D AND TECHNOLOGICAL ADVANCEMENTS IN THE HTS MARKET ARE KEY GROWTH DRIVERS
4.2 NORTH AMERICA: HIGH-THROUGHPUT SCREENING MARKET, MARKET SHARE (2019)
FIGURE 16 CONSUMABLES COMMANDED THE LARGEST SHARE OF THE NORTH AMERICAN HIGH-THROUGHPUT SCREENING MARKET IN 2019
4.3 HIGH-THROUGHPUT SCREENING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 17 CHINA TO WITNESS THE HIGHEST GROWTH RATE IN THE HTS MARKET DURING THE FORECAST PERIOD
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 18 HIGH-THROUGHPUT SCREENING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 MARKET DRIVERS
5.2.1.1 The growing adoption of open innovation models in pharmaceutical & biotechnology companies
5.2.1.2 Government funding and venture capital investments
5.2.1.3 Increasing R&D spending
TABLE 1 INCREASE IN COMPANY R&D EXPENDITURE (2018–2019)
5.2.1.4 Technological advancements in the HTS market
5.2.2 MARKET RESTRAINTS
5.2.2.1 The capital-intensive nature of HTS instruments
5.2.2.2 Complexities in assay development
5.2.3 MARKET OPPORTUNITIES
5.2.3.1 Emerging markets
5.2.3.2 Growing applications in stem cell research
5.2.4 MARKET CHALLENGES
5.2.4.1 The dearth of skilled operators
FIGURE 19 FUNCTIONAL AREAS WITH DIFFICULT TO FILL POSITIONS
5.3 IMPACT OF THE COVID-19 ON THE MARKET
5.3.1 COVID-19 VACCINE CANDIDATES: KEY DEVELOPMENTS
5.3.2 COVID-19 DRUG R&D: VACCINE PRODUCTION SCENARIO, BY COUNTRY
5.4 TECHNOLOGY ANALYSIS
5.4.1 LABEL-FREE TECHNOLOGY
5.4.2 AUTOMATION & MINIATURIZATION
5.4.3 MICROFLUIDICS
5.5 PRICING ANALYSIS
5.6 VALUE CHAIN ANALYSIS
FIGURE 20 MAJOR VALUE IS ADDED DURING THE MANUFACTURING AND
ASSEMBLY PHASE
5.7 SUPPLY CHAIN ANALYSIS
FIGURE 21 DIRECT DISTRIBUTION—STRATEGY PREFERRED BY PROMINENT COMPANIES
5.8 ECOSYSTEM ANALYSIS OF THE HTS MARKET
FIGURE 22 ECOSYSTEM ANALYSIS OF THE HTS MARKET
5.9 PORTER’S FIVE FORCES ANALYSIS
FIGURE 23 HIGH CAPITAL INVESTMENTS TO RESTRICT THE ENTRY OF NEW PLAYERS
5.9.1 THREAT OF NEW ENTRANTS
5.9.2 THREAT OF SUBSTITUTES
5.9.3 BARGAINING POWER OF BUYERS
5.9.4 BARGAINING POWER OF SUPPLIERS
5.9.5 INTENSITY OF COMPETITIVE RIVALRY
5.10 REGULATORY ANALYSIS
5.11 PATENT ANALYSIS
FIGURE 24 NO OF PATENT GRANTED FOR HIGH THROUGHPUT SCREENING METHOD DEVELOPMENT, JANUARY 2010 - DECEMBER 2020
6 HIGH-THROUGHPUT SCREENING MARKET, BY PRODUCT & SERVICE
6.1 INTRODUCTION
TABLE 2 HIGH-THROUGHPUT SCREENING MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
6.2 CONSUMABLES
TABLE 3 HTS CONSUMABLES MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 4 NORTH AMERICA: CONSUMABLES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 5 EUROPE: CONSUMABLES MARKET, BY COUNTRY/REGION, 2018–2025 (USD MILLION)
TABLE 6 ASIA PACIFIC: CONSUMABLES MARKET, BY COUNTRY/REGION, 2018–2025 (USD MILLION)
TABLE 7 ROW: CONSUMABLES MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 8 HTS CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION)
6.2.1 REAGENTS & ASSAY KITS
6.2.1.1 Reagents & assay kits accounted for the largest share of the consumables segment in 2019
TABLE 9 REAGENTS & ASSAY KITS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 10 NORTH AMERICA: REAGENTS & ASSAY KITS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 11 EUROPE: REAGENTS & ASSAY KITS MARKET, BY COUNTRY/REGION, 2018–2025 (USD MILLION)
TABLE 12 ASIA PACIFIC: REAGENTS & ASSAY KITS MARKET, BY COUNTRY/REGION, 2018–2025 (USD MILLION)
TABLE 13 ROW: REAGENTS & ASSAY KITS MARKET, BY REGION, 2018–2025 (USD MILLION)
6.2.2 LABORATORY EQUIPMENT
6.2.2.1 The development of high-quality equipment by market players will propel market growth
TABLE 14 LABORATORY EQUIPMENT MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 15 NORTH AMERICA: LABORATORY EQUIPMENT MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 16 EUROPE: LABORATORY EQUIPMENT MARKET, BY COUNTRY/REGION, 2018–2025 (USD MILLION)
TABLE 17 ASIA PACIFIC: LABORATORY EQUIPMENT MARKET, BY COUNTRY/REGION, 2018–2025 (USD MILLION)
TABLE 18 ROW: LABORATORY EQUIPMENT MARKET, BY REGION, 2018–2025 (USD MILLION)
6.3 INSTRUMENTS
TABLE 19 HTS INSTRUMENTS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 20 NORTH AMERICA: INSTRUMENTS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 21 EUROPE: INSTRUMENTS MARKET, BY COUNTRY/REGION, 2018–2025 (USD MILLION)
TABLE 22 ASIA PACIFIC: INSTRUMENTS MARKET, BY COUNTRY/REGION, 2018–2025 (USD MILLION)
TABLE 23 ROW: INSTRUMENTS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 24 HTS INSTRUMENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
6.3.1 LIQUID HANDLING SYSTEMS
6.3.1.1 The liquid handling systems segment is projected to witness the highest growth rate during the forecast period
TABLE 25 LIQUID HANDLING SYSTEMS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 26 NORTH AMERICA: LIQUID HANDLING SYSTEMS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 27 EUROPE: LIQUID HANDLING SYSTEMS MARKET, BY COUNTRY/REGION, 2018–2025 (USD MILLION)
TABLE 28 ASIA PACIFIC: LIQUID HANDLING SYSTEMS MARKET, BY COUNTRY/REGION, 2018–2025 (USD MILLION)
TABLE 29 ROW: LIQUID HANDLING SYSTEMS MARKET, BY REGION, 2018–2025 (USD MILLION)
6.3.2 DETECTION SYSTEMS
6.3.2.1 Growth in this segment can be attributed to technological advancements in automation
TABLE 30 DETECTION SYSTEMS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 31 NORTH AMERICA: DETECTION SYSTEMS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 32 EUROPE: DETECTION SYSTEMS MARKET, BY COUNTRY/REGION, 2018–2025 (USD MILLION)
TABLE 33 ASIA PACIFIC: DETECTION SYSTEMS MARKET, BY COUNTRY/REGION, 2018–2025 (USD MILLION)
TABLE 34 ROW: DETECTION SYSTEMS MARKET, BY REGION, 2018–2025 (USD MILLION)
6.3.3 OTHER INSTRUMENTS
TABLE 35 OTHER INSTRUMENTS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 36 NORTH AMERICA: OTHER INSTRUMENTS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 37 EUROPE: OTHER INSTRUMENTS MARKET, BY COUNTRY/REGION, 2018–2025 (USD MILLION)
TABLE 38 ASIA PACIFIC: OTHER INSTRUMENTS MARKET, BY COUNTRY/REGION, 2018–2025 (USD MILLION)
TABLE 39 ROW: OTHER INSTRUMENTS MARKET, BY REGION, 2018–2025 (USD MILLION)
6.4 SERVICES
6.4.1 THIS SEGMENT IS PROJECTED TO GROW AT THE HIGHEST CAGR DUE TO THE INCREASING OUTSOURCING OF R&D ACTIVITIES IN EMERGING MARKETS
TABLE 40 HTS SERVICES MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 41 NORTH AMERICA: SERVICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 42 EUROPE: SERVICES MARKET, BY COUNTRY/REGION, 2018–2025 (USD MILLION)
TABLE 43 ASIA PACIFIC: SERVICES MARKET, BY COUNTRY/REGION, 2018–2025 (USD MILLION)
TABLE 44 ROW: SERVICES MARKET, BY REGION, 2018–2025 (USD MILLION)
6.5 SOFTWARE
6.5.1 AUTOMATION IN HTS AND THE AVAILABILITY OF ROBUST DATA MANAGEMENT SOFTWARE TOOLS TO DRIVE MARKET GROWTH
TABLE 45 HTS SOFTWARE MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 46 NORTH AMERICA: SOFTWARE MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 47 EUROPE: SOFTWARE MARKET, BY COUNTRY/REGION, 2018–2025 (USD MILLION)
TABLE 48 ASIA PACIFIC: SOFTWARE MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 49 ROW: SOFTWARE MARKET, BY REGION, 2018–2025 (USD MILLION)
7 HIGH-THROUGHPUT SCREENING MARKET, BY TECHNOLOGY
7.1 INTRODUCTION
TABLE 50 HIGH-THROUGHPUT SCREENING MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
7.2 CELL-BASED ASSAYS
TABLE 51 HTS FOR CELL-BASED ASSAYS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 52 CELL-BASED ASSAYS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 53 NORTH AMERICA: CELL- BASED ASSAYS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 54 EUROPE: CELL-BASED ASSAYS MARKET, BY COUNTRY/REGION, 2018–2025 (USD MILLION)
TABLE 55 ASIA PACIFIC: CELL-BASED ASSAYS MARKET, BY COUNTRY/REGION, 2018–2025 (USD MILLION)
TABLE 56 ROW: CELL-BASED ASSAYS MARKET, BY REGION, 2018–2025 (USD MILLION)
7.2.1 2D CELL CULTURE
7.2.1.1 Market growth can be attributed to the cost-effectiveness of 2D cell culture systems
TABLE 57 2D CELL CULTURE MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 58 NORTH AMERICA: 2D CELL CULTURE MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 59 EUROPE: 2D CELL CULTURE MARKET, BY COUNTRY/REGION, 2018–2025 (USD MILLION)
TABLE 60 ASIA PACIFIC: 2D CELL CULTURE MARKET, BY COUNTRY/REGION, 2018–2025 (USD MILLION)
TABLE 61 ROW: 2D CELL CULTURE MARKET, BY REGION, 2018–2025 (USD MILLION)
7.2.2 3D CELL CULTURE
TABLE 62 3D CELL CULTURE MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 63 3D CELL CULTURE MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 64 NORTH AMERICA: 3D CELL CULTURE MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 65 EUROPE: 3D CELL CULTURE MARKET, BY COUNTRY/REGION, 2018–2025 (USD MILLION)
TABLE 66 ASIA PACIFIC: 3D CELL CULTURE MARKET, BY COUNTRY/REGION, 2018–2025 (USD MILLION)
TABLE 67 ROW: 3D CELL CULTURE MARKET, BY REGION, 2018–2025 (USD MILLION)
7.2.2.1 Scaffold-based technology
TABLE 68 SCAFFOLD-BASED TECHNOLOGY MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 69 SCAFFOLD-BASED TECHNOLOGY MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 70 NORTH AMERICA: SCAFFOLD-BASED TECHNOLOGY MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 71 EUROPE: SCAFFOLD-BASED TECHNOLOGY MARKET, BY COUNTRY/REGION, 2018–2025 (USD MILLION)
TABLE 72 ASIA PACIFIC: SCAFFOLD-BASED TECHNOLOGY MARKET, BY COUNTRY/REGION, 2018–2025 (USD MILLION)
TABLE 73 ROW: SCAFFOLD-BASED TECHNOLOGY MARKET, BY REGION, 2018–2025 (USD MILLION)
7.2.2.1.1 Hydrogels
TABLE 74 HYDROGELS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 75 HYDROGELS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 76 NORTH AMERICA: HYDROGELS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 77 EUROPE: HYDROGELS MARKET, BY COUNTRY/REGION, 2018–2025 (USD MILLION)
TABLE 78 ASIA PACIFIC: HYDROGELS MARKET, BY COUNTRY/REGION, 2018–2025 (USD MILLION)
TABLE 79 ROW: HYDROGELS MARKET, BY REGION, 2018–2025 (USD MILLION)
7.2.2.1.1.1 Animal-derived hydrogels
TABLE 80 ANIMAL-DERIVED HYDROGELS MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 81 ANIMAL-DERIVED HYDROGELS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 82 NORTH AMERICA: ANIMAL-DERIVED HYDROGELS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 83 EUROPE: ANIMAL-DERIVED HYDROGELS MARKET, BY COUNTRY/REGION, 2018–2025 (USD MILLION)
TABLE 84 ASIA PACIFIC: ANIMAL-DERIVED HYDROGELS MARKET, BY COUNTRY/REGION, 2018–2025 (USD MILLION)
TABLE 85 ROW: ANIMAL-DERIVED HYDROGELS MARKET, BY REGION, 2018–2025 (USD MILLION)
7.2.2.1.1.1.1 Matrigel
7.2.2.1.1.1.1.1 The Matrigel segment accounted for the largest share of the animal-derived hydrogels market in 2019
TABLE 86 MATRIGEL MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 87 NORTH AMERICA: MATRIGEL MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 88 EUROPE: MATRIGEL MARKET, BY COUNTRY/REGION, 2018–2025 (USD MILLION)
TABLE 89 ASIA PACIFIC: MATRIGEL MARKET, BY COUNTRY/REGION, 2018–2025 (USD MILLION)
TABLE 90 ROW: MATRIGEL MARKET, BY REGION, 2018–2025 (USD MILLION)
7.2.2.1.1.1.2 Collagen
TABLE 91 COLLAGEN MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 92 NORTH AMERICA: COLLAGEN MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 93 EUROPE: COLLAGEN MARKET, BY COUNTRY/REGION, 2018–2025 (USD MILLION)
TABLE 94 ASIA PACIFIC: COLLAGEN MARKET, BY COUNTRY/REGION, 2018–2025 (USD MILLION)
TABLE 95 ROW: COLLAGEN MARKET, BY REGION, 2018–2025 (USD MILLION)
7.2.2.1.1.2 Synthetic hydrogels
7.2.2.1.1.2.1 The long service life and high gel strength of synthetic hydrogels drive the market growth
TABLE 96 SYNTHETIC HYDROGELS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 97 NORTH AMERICA: SYNTHETIC HYDROGELS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 98 EUROPE: SYNTHETIC HYDROGELS MARKET, BY COUNTRY/REGION, 2018–2025 (USD MILLION)
TABLE 99 ASIA PACIFIC: SYNTHETIC HYDROGELS MARKET, BY COUNTRY/REGION, 2018–2025 (USD MILLION)
TABLE 100 ROW: SYNTHETIC HYDROGELS MARKET, BY REGION, 2018–2025 (USD MILLION)
7.2.2.1.1.3 Alginate/Agarose
7.2.2.1.1.3.1 This technique is used to culture cells in soft agar gels from plant sources like algae
TABLE 101 ALGINATE/AGAROSE MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 102 NORTH AMERICA: ALGINATE/AGAROSE MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 103 EUROPE: ALGINATE/AGAROSE MARKET, BY COUNTRY/REGION, 2018–2025 (USD MILLION)
TABLE 104 ASIA PACIFIC: ALGINATE/AGAROSE MARKET, BY COUNTRY/REGION, 2018–2025 (USD MILLION)
TABLE 105 ROW: ALGINATE/AGAROSE MARKET, BY REGION, 2018–2025 (USD MILLION)
7.2.2.1.2 Inert matrix/Solid scaffolds
7.2.2.1.2.1 This technique minimizes batch-to-batch variation and promotes better reproducibility & consistency to the cell culture
TABLE 106 INERT MATRIX/SOLID SCAFFOLDS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 107 NORTH AMERICA: INERT MATRIX/SOLID SCAFFOLDS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 108 EUROPE: INERT MATRIX/SOLID SCAFFOLDS MARKET, BY COUNTRY/REGION, 2018–2025 (USD MILLION)
TABLE 109 ASIA PACIFIC: INERT MATRIX/SOLID SCAFFOLDS MARKET, BY COUNTRY/REGION, 2018–2025 (USD MILLION)
TABLE 110 ROW: INERT MATRIX/SOLID SCAFFOLDS MARKET, BY REGION, 2018–2025 (USD MILLION)
7.2.2.1.3 Micropatterned surfaces
7.2.2.1.3.1 Micropatterned surfaces enhance the expression of enzymes levels and drug reactivity in cell cultures
TABLE 111 MICROPATTERNED SURFACES MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 112 NORTH AMERICA: MICROPATTERNED SURFACES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 113 EUROPE: MICROPATTERNED SURFACES MARKET, BY COUNTRY/REGION, 2018–2025 (USD MILLION)
TABLE 114 ASIA PACIFIC: MICROPATTERNED SURFACES MARKET, BY COUNTRY/REGION, 2018–2025 (USD MILLION)
TABLE 115 ROW: MICROPATTERNED SURFACES MARKET, BY REGION, 2018–2025 (USD MILLION)
7.2.2.2 Scaffold-free technology
TABLE 116 SCAFFOLD-FREE TECHNOLOGY MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 117 SCAFFOLD-FREE TECHNOLOGY MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 118 NORTH AMERICA: SCAFFOLD-FREE TECHNOLOGY MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 119 EUROPE: SCAFFOLD-FREE TECHNOLOGY MARKET, BY COUNTRY/REGION, 2018–2025 (USD MILLION)
TABLE 120 ASIA PACIFIC: SCAFFOLD-FREE TECHNOLOGY MARKET, BY COUNTRY/REGION, 2018–2025 (USD MILLION)
TABLE 121 ROW: SCAFFOLD-FREE TECHNOLOGY MARKET, BY REGION, 2018–2025 (USD MILLION)
7.2.2.2.1 Ultra-low binding plates
7.2.2.2.1.1 This segment accounted for the largest share of the scaffold-free technology market in 2019
TABLE 122 ULTRA-LOW BINDING PLATES MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 123 NORTH AMERICA: ULTRA-LOW BINDING PLATES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 124 EUROPE: ULTRA-LOW BINDING PLATES MARKET, BY COUNTRY/REGION, 2018–2025 (USD MILLION)
TABLE 125 ASIA PACIFIC: ULTRA-LOW BINDING PLATES MARKET, BY COUNTRY/REGION, 2018–2025 (USD MILLION)
TABLE 126 ROW: ULTRA-LOW BINDING PLATES MARKET, BY REGION, 2018–2025 (USD MILLION)
7.2.2.2.2 Hanging-drop plates
7.2.2.2.2.1 The cost-effectiveness of hanging-drop plates over other methods for 3D cell culture drives the market growth
TABLE 127 HANGING-DROP PLATES MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 128 NORTH AMERICA: HANGING-DROP PLATES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 129 EUROPE: HANGING-DROP PLATES MARKET, BY COUNTRY/REGION, 2018–2025 (USD MILLION)
TABLE 130 ASIA PACIFIC: HANGING-DROP PLATES MARKET, BY COUNTRY/REGION, 2018–2025 (USD MILLION)
TABLE 131 ROW: HANGING-DROP PLATES MARKET, BY REGION, 2018–2025 (USD MILLION)
7.2.2.2.3 Other scaffold-free technologies
TABLE 132 OTHER SCAFFOLD-FREE TECHNOLOGIES MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 133 NORTH AMERICA: OTHER SCAFFOLD-FREE TECHNOLOGIES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 134 EUROPE: OTHER SCAFFOLD-FREE TECHNOLOGIES MARKET, BY COUNTRY/REGION, 2018–2025 (USD MILLION)
TABLE 135 ASIA PACIFIC: OTHER SCAFFOLD-FREE TECHNOLOGIES MARKET, BY COUNTRY/REGION, 2018–2025 (USD MILLION)
TABLE 136 ROW: OTHER SCAFFOLD-FREE TECHNOLOGIES MARKET, BY REGION, 2018–2025 (USD MILLION)
7.2.3 REPORTER-BASED ASSAYS
7.2.3.1 Growing applications of gene expression will support the market growth of this segment
TABLE 137 REPORTER-BASED ASSAYS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 138 NORTH AMERICA: REPORTER-BASED ASSAYS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 139 EUROPE: REPORTER-BASED ASSAYS MARKET, BY COUNTRY/REGION, 2018–2025 (USD MILLION)
TABLE 140 ASIA PACIFIC: REPORTER-BASED ASSAYS MARKET, BY COUNTRY/REGION, 2018–2025 (USD MILLION)
TABLE 141 ROW: REPORTER-BASED ASSAYS MARKET, BY REGION, 2018–2025 (USD MILLION)
7.2.4 PERFUSION CELL CULTURE
7.2.4.1 Perfusion cell culture provides higher product output as compared to traditional techniques
TABLE 142 PERFUSION CELL CULTURE MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 143 NORTH AMERICA: PERFUSION CELL CULTURE MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 144 EUROPE: PERFUSION CELL CULTURE MARKET, BY COUNTRY/REGION, 2018–2025 (USD MILLION)
TABLE 145 ASIA PACIFIC: PERFUSION CELL CULTURE MARKET, BY COUNTRY/REGION, 2018–2025 (USD MILLION)
TABLE 146 ROW: PERFUSION CELL CULTURE MARKET, BY REGION, 2018–2025 (USD MILLION)
7.3 LAB-ON-A-CHIP TECHNOLOGY (LOC)
7.3.1 MARKET GROWTH CAN BE ATTRIBUTED TO COST-EFFECTIVENESS OF THE TECHNIQUE OWING TO THE LOW CONSUMPTION OF REAGENTS
TABLE 147 HTS FOR LAB-ON-A-CHIP TECHNOLOGY MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 148 NORTH AMERICA: LAB-ON-A-CHIP TECHNOLOGY MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 149 EUROPE: LAB-ON-A-CHIP TECHNOLOGY MARKET, BY COUNTRY/REGION, 2018–2025 (USD MILLION)
TABLE 150 ASIA PACIFIC: LAB-ON-A-CHIP TECHNOLOGY MARKET, BY COUNTRY/REGION, 2018–2025 (USD MILLION)
TABLE 151 ROW: LAB-ON-A-CHIP TECHNOLOGY MARKET, BY REGION, 2018–2025 (USD MILLION)
7.4 LABEL-FREE TECHNOLOGY
7.4.1 LABEL-FREE TECHNOLOGY ENABLES THE INVESTIGATION OF BIOMOLECULAR INTERACTIONS WITHOUT THE EFFECTS OF LABELS
TABLE 152 HTS FOR LABEL-FREE TECHNOLOGY MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 153 NORTH AMERICA: LABEL-FREE TECHNOLOGY MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 154 EUROPE: LABEL-FREE TECHNOLOGY, BY COUNTRY/REGION, 2018–2025 (USD MILLION)
TABLE 155 ASIA PACIFIC: LABEL-FREE TECHNOLOGY, BY COUNTRY/REGION, 2018–2025 (USD MILLION)
TABLE 156 ROW: LABEL-FREE TECHNOLOGY, BY REGION, 2018–2025 (USD MILLION)
8 HIGH-THROUGHPUT SCREENING MARKET, BY APPLICATION
8.1 INTRODUCTION
TABLE 157 GLOBAL HIGH-THROUGHPUT SCREENING MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
8.2 DRUG DISCOVERY
8.2.1 INCREASING DEMAND FOR DRUGS IN THE TREATMENT OF VARIOUS DISEASES TO DRIVE MARKET GROWTH
TABLE 158 DRUG DISCOVERY MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 159 NORTH AMERICA: DRUG DISCOVERY MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 160 EUROPE: DRUG DISCOVERY MARKET, BY COUNTRY/REGION, 2018–2025 (USD MILLION)
TABLE 161 ASIA PACIFIC: DRUG DISCOVERY MARKET, BY COUNTRY/REGION, 2018–2025 (USD MILLION)
TABLE 162 ROW: DRUG DISCOVERY MARKET, BY REGION, 2018–2025 (USD MILLION)
8.3 BIOCHEMICAL SCREENING
8.3.1 THE INCREASING AWARENESS OF GENETIC DISORDERS AND SCREENING TESTS TO DRIVE MARKET GROWTH
TABLE 163 BIOCHEMICAL SCREENING MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 164 NORTH AMERICA: BIOCHEMICAL SCREENING MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 165 EUROPE: BIOCHEMICAL SCREENING MARKET, BY COUNTRY/REGION, 2018–2025 (USD MILLION)
TABLE 166 ASIA PACIFIC: BIOCHEMICAL SCREENING MARKET, BY COUNTRY/REGION, 2018–2025 (USD MILLION)
TABLE 167 ROW: BIOCHEMICAL SCREENING MARKET, BY REGION, 2018–2025 (USD MILLION)
8.4 LIFE SCIENCES RESEARCH
8.4.1 INCREASING INVESTMENTS IN STEM CELL RESEARCH & THE STUDY OF INFECTIOUS DISEASES TO CONTRIBUTE TO MARKET GROWTH
TABLE 168 LIFE SCIENCES RESEARCH MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 169 NORTH AMERICA: LIFE SCIENCES RESEARCH MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 170 EUROPE: LIFE SCIENCES RESEARCH MARKET, BY COUNTRY/REGION, 2018–2025 (USD MILLION)
TABLE 171 ASIA PACIFIC: LIFE SCIENCES RESEARCH MARKET, BY COUNTRY/REGION, 2018–2025 (USD MILLION)
TABLE 172 ROW: LIFE SCIENCES RESEARCH MARKET, BY REGION, 2018–2025 (USD MILLION)
8.5 OTHER APPLICATIONS
TABLE 173 OTHER APPLICATIONS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 174 NORTH AMERICA: OTHER APPLICATIONS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 175 EUROPE: OTHER APPLICATIONS MARKET, BY COUNTRY/REGION, 2018–2025 (USD MILLION)
TABLE 176 ASIA PACIFIC: OTHER APPLICATIONS MARKET, BY COUNTRY/REGION, 2018–2025 (USD MILLION)
TABLE 177 ROW: OTHER APPLICATIONS MARKET, BY REGION, 2018–2025 (USD MILLION)
9 HIGH-THROUGHPUT SCREENING MARKET, BY END USER
9.1 INTRODUCTION
TABLE 178 HIGH-THROUGHPUT SCREENING MARKET, BY END USER, 2018–2025 (USD MILLION)
9.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
9.2.1 RISING R&D SPENDING BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO SUPPORT MARKET GROWTH
TABLE 179 HTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2025 (USD MILLION)
TABLE 180 NORTH AMERICA: HTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018-2025 (USD MILLION)
TABLE 181 EUROPE: HTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY/REGION, 2018-2025 (USD MILLION)
TABLE 182 ASIA PACIFIC: HTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY/REGION, 2018-2025 (USD MILLION)
TABLE 183 ROW: HTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2025 (USD MILLION)
9.3 ACADEMIC & RESEARCH INSTITUTES
9.3.1 COLLABORATIONS BETWEEN PHARMACEUTICAL COMPANIES AND RESEARCHERS TO CONTRIBUTE TO THE GROWTH OF THIS MARKET
TABLE 184 HTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018–2025 (USD MILLION)
TABLE 185 NORTH AMERICA: HTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2018-2025 (USD MILLION)
TABLE 186 EUROPE: HTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY/REGION, 2018-2025 (USD MILLION)
TABLE 187 ASIA PACIFIC: HTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY/REGION, 2018-2025 (USD MILLION)
TABLE 188 ROW: HTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2025 (USD MILLION)
9.4 CONTRACT RESEARCH ORGANIZATIONS (CROS)
9.4.1 INCREASING OUTSOURCING OF R&D ACTIVITIES TO DRIVE MARKET GROWTH FOR CROS
TABLE 189 HTS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018–2025 (USD MILLION)
TABLE 190 NORTH AMERICA: HTS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018-2025 (USD MILLION)
TABLE 191 EUROPE: HTS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY/REGION, 2018-2025 (USD MILLION)
TABLE 192 ASIA PACIFIC: HTS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY/REGION, 2018-2025 (USD MILLION)
TABLE 193 ROW: HTS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2025 (USD MILLION)
9.5 OTHER END USERS
TABLE 194 HTS MARKET FOR OTHER END USERS, BY REGION, 2018–2025 (USD MILLION)
TABLE 195 NORTH AMERICA: HTS MARKET FOR OTHER END USERS, BY COUNTRY, 2018-2025 (USD MILLION)
TABLE 196 EUROPE: HTS MARKET FOR OTHER END USERS, BY COUNTRY/REGION, 2018-2025 (USD MILLION)
TABLE 197 ASIA PACIFIC: HTS MARKET FOR OTHER END USERS, BY COUNTRY/REGION, 2018-2025 (USD MILLION)
TABLE 198 ROW: HTS MARKET FOR OTHER END USERS, BY REGION, 2018-2025 (USD MILLION)
10 HIGH-THROUGHPUT SCREENING MARKET, BY REGION
10.1 INTRODUCTION
TABLE 199 HTS MARKET, BY REGION, 2018–2025 (USD MILLION)
10.2 NORTH AMERICA
FIGURE 25 NORTH AMERICA: HIGH-THROUGHPUT SCREENING MARKET SNAPSHOT
TABLE 200 NORTH AMERICA: HTS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 201 NORTH AMERICA: HTS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 202 NORTH AMERICA: CELL-BASED ASSAYS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 203 NORTH AMERICA: 3D CELL CULTURE MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 204 NORTH AMERICA: SCAFFOLD-BASED TECHNOLOGIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 205 NORTH AMERICA: HYDROGELS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 206 NORTH AMERICA: ANIMAL-DERIVED HYDROGELS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 207 NORTH AMERICA: SCAFFOLD-FREE TECHNOLOGIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 208 NORTH AMERICA: HTS MARKET, BY PRODUCT AND SERVICE, 2018–2025 (USD MILLION)
TABLE 209 NORTH AMERICA: CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 210 NORTH AMERICA: INSTRUMENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 211 NORTH AMERICA: HTS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 212 NORTH AMERICA: HTS MARKET, BY END USER, 2018–2025 (USD MILLION)
10.2.1 US
10.2.1.1 Market growth is attributed to rising government funding for research activities in the US
TABLE 213 NIH BUDGET FOR VARIOUS DISCIPLINES IN 2019 AND 2020
TABLE 214 US: HTS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 215 US: CELL-BASED ASSAYS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 216 US: 3D CELL CULTURE MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 217 US: SCAFFOLD-BASED TECHNOLOGIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 218 US: HYDROGELS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 219 US: ANIMAL-DERIVED HYDROGELS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 220 US: SCAFFOLD-FREE TECHNOLOGIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 221 US: HTS MARKET, BY PRODUCT AND SERVICE, 2018–2025 (USD MILLION)
TABLE 222 US: CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 223 US: INSTRUMENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 224 US: HTS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 225 US: HTS MARKET, BY END USER, 2018–2025 (USD MILLION)
10.2.2 CANADA
10.2.2.1 Government funding to promote drug discovery will support market growth in Canada
TABLE 226 CANADA: HTS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 227 CANADA: CELL-BASED ASSAYS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 228 CANADA: 3D CELL CULTURE MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 229 CANADA: SCAFFOLD-BASED TECHNOLOGIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 230 CANADA: HYDROGELS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 231 CANADA: ANIMAL-DERIVED HYDROGELS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 232 CANADA: SCAFFOLD-FREE TECHNOLOGIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 233 CANADA: HTS MARKET, BY PRODUCT AND SERVICE, 2018–2025 (USD MILLION)
TABLE 234 CANADA: CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 235 CANADA: INSTRUMENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 236 CANADA: HTS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 237 CANADA: HTS MARKET, BY END USER, 2018–2025 (USD MILLION)
10.2.3 EUROPE
TABLE 238 EUROPE: HTS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 239 EUROPE: HTS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 240 EUROPE: CELL-BASED ASSAYS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 241 EUROPE: 3D CELL CULTURE MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 242 EUROPE: SCAFFOLD-BASED TECHNOLOGIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 243 EUROPE: HYDROGELS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 244 EUROPE: ANIMAL-DERIVED HYDROGELS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 245 EUROPE: SCAFFOLD-FREE TECHNOLOGIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 246 EUROPE: HTS MARKET, BY PRODUCT AND SERVICE, 2018–2025 (USD MILLION)
TABLE 247 EUROPE: CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 248 EUROPE: INSTRUMENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 249 EUROPE: HTS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 250 EUROPE: HTS MARKET, BY END USER, 2018–2025 (USD MILLION)
10.2.4 GERMANY
10.2.4.1 Increasing research activities for HTS to drive market growth in Germany
TABLE 251 GERMANY: HTS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 252 GERMANY: CELL-BASED ASSAYS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 253 GERMANY: 3D CELL CULTURE MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 254 GERMANY: SCAFFOLD-BASED TECHNOLOGIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 255 GERMANY: HYDROGELS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 256 GERMANY: ANIMAL-DERIVED HYDROGELS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 257 GERMANY: SCAFFOLD-FREE TECHNOLOGIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 258 GERMANY: HTS MARKET, BY PRODUCT AND SERVICE, 2018–2025 (USD MILLION)
TABLE 259 GERMANY: CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 260 GERMANY: INSTRUMENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 261 GERMANY: HTS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 262 GERMANY: HTS MARKET, BY END USER, 2018–2025 (USD MILLION)
10.2.5 UK
10.2.5.1 Government funding for the domestic production of pharmaceutical products to drive market growth in the UK
TABLE 263 UK: HTS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 264 UK: CELL-BASED ASSAYS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 265 UK: 3D CELL CULTURE MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 266 UK: SCAFFOLD-BASED TECHNOLOGIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 267 UK: HYDROGELS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 268 UK: ANIMAL-DERIVED HYDROGELS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 269 UK: SCAFFOLD-FREE TECHNOLOGIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 270 UK: HTS MARKET, BY PRODUCT AND SERVICE, 2018–2025 (USD MILLION)
TABLE 271 UK: CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 272 UK: INSTRUMENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 273 UK: HTS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 274 UK: HTS MARKET, BY END USER, 2018–2025 (USD MILLION)
10.2.6 FRANCE
10.2.6.1 The growing pharmaceutical industry in France will support market growth for HTS technologies
TABLE 275 FRANCE: HTS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 276 FRANCE: CELL-BASED ASSAYS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 277 FRANCE: 3D CELL CULTURE MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 278 FRANCE: SCAFFOLD-BASED TECHNOLOGIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 279 FRANCE: HYDROGELS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 280 FRANCE: ANIMAL-DERIVED HYDROGELS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 281 FRANCE: SCAFFOLD-FREE TECHNOLOGIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 282 FRANCE: HTS MARKET, BY PRODUCT AND SERVICE, 2018–2025 (USD MILLION)
TABLE 283 FRANCE: CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 284 FRANCE: INSTRUMENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 285 FRANCE: HTS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 286 FRANCE: HTS MARKET, BY END USER, 2018–2025 (USD MILLION)
10.2.7 ITALY
10.2.7.1 Growing industry-academia collaborations to drive market growth in Italy
TABLE 287 ITALY: HTS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 288 ITALY: CELL-BASED ASSAYS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 289 ITALY: 3D CELL CULTURE MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 290 ITALY: SCAFFOLD-BASED TECHNOLOGIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 291 ITALY: HYDROGELS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 292 ITALY: ANIMAL-DERIVED HYDROGELS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 293 ITALY: SCAFFOLD-FREE TECHNOLOGIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 294 ITALY: HTS MARKET, BY PRODUCT AND SERVICE, 2018–2025 (USD MILLION)
TABLE 295 ITALY: CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 296 ITALY: INSTRUMENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 297 ITALY: HTS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 298 ITALY: HTS MARKET, BY END USER, 2018–2025 (USD MILLION)
10.2.8 SPAIN
10.2.8.1 A nationwide research network supported by funding for various programs will drive market growth in Spain
TABLE 299 SPAIN: HTS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 300 SPAIN: CELL-BASED ASSAYS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 301 SPAIN: 3D CELL CULTURE MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 302 SPAIN: SCAFFOLD-BASED TECHNOLOGIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 303 SPAIN: HYDROGELS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 304 SPAIN: ANIMAL-DERIVED HYDROGELS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 305 SPAIN: SCAFFOLD-FREE TECHNOLOGIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 306 SPAIN: HTS MARKET, BY PRODUCT AND SERVICE, 2018–2025 (USD MILLION)
TABLE 307 SPAIN: CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 308 SPAIN: INSTRUMENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 309 SPAIN: HTS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 310 SPAIN: HTS MARKET, BY END USER, 2018–2025 (USD MILLION)
10.2.9 REST OF EUROPE
TABLE 311 ROE: HTS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 312 ROE: CELL-BASED ASSAYS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 313 ROE: 3D CELL CULTURE MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 314 ROE: SCAFFOLD-BASED TECHNOLOGIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 315 ROE: HYDROGELS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 316 ROE: ANIMAL-DERIVED HYDROGELS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 317 ROE: SCAFFOLD-FREE TECHNOLOGIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 318 ROE: HTS MARKET, BY PRODUCT AND SERVICE, 2018–2025 (USD MILLION)
TABLE 319 ROE: CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 320 ROE: INSTRUMENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 321 ROE: HTS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 322 ROE: HTS MARKET, BY END USER, 2018–2025 (USD MILLION)
10.3 ASIA PACIFIC
FIGURE 26 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING MARKET SNAPSHOT
TABLE 323 ASIA PACIFIC: HTS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 324 ASIA PACIFIC: HTS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 325 ASIA PACIFIC: CELL-BASED ASSAYS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 326 ASIA PACIFIC: 3D CELL CULTURE MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 327 ASIA PACIFIC: SCAFFOLD-BASED TECHNOLOGIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 328 ASIA PACIFIC: HYDROGELS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 329 ASIA PACIFIC: ANIMAL-DERIVED HYDROGELS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 330 ASIA PACIFIC: SCAFFOLD-FREE TECHNOLOGIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 331 ASIA PACIFIC: HTS MARKET, BY PRODUCT AND SERVICE, 2018–2025 (USD MILLION)
TABLE 332 ASIA PACIFIC: CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 333 ASIA PACIFIC: INSTRUMENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 334 ASIA PACIFIC: HTS MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 335 ASIA PACIFIC: HTS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
10.3.1 CHINA
10.3.1.1 The rising number of CROs in China supports market growth for HTS
TABLE 336 CHINA: HTS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 337 CHINA: CELL-BASED ASSAYS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 338 CHINA: 3D CELL CULTURE MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 339 CHINA: SCAFFOLD-BASED TECHNOLOGIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 340 CHINA: HYDROGELS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 341 CHINA: ANIMAL-DERIVED HYDROGELS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 342 CHINA: SCAFFOLD-FREE TECHNOLOGIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 343 CHINA: HTS MARKET, BY PRODUCT AND SERVICE, 2018–2025 (USD MILLION)
TABLE 344 CHINA: CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 345 CHINA: INSTRUMENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 346 CHINA: HTS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 347 CHINA: HTS MARKET, BY END USER, 2018–2025 (USD MILLION)
10.3.2 JAPAN
10.3.2.1 High R&D expenditure by pharmaceutical companies to drive market growth in Japan
TABLE 348 JAPAN: HTS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 349 JAPAN: CELL-BASED ASSAYS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 350 JAPAN: 3D CELL CULTURE MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 351 JAPAN: SCAFFOLD-BASED TECHNOLOGIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 352 JAPAN: HYDROGELS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 353 JAPAN: ANIMAL-DERIVED HYDROGELS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 354 JAPAN: SCAFFOLD-FREE TECHNOLOGIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 355 JAPAN: HTS MARKET, BY PRODUCT AND SERVICE, 2018–2025 (USD MILLION)
TABLE 356 JAPAN: CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 357 JAPAN: INSTRUMENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 358 JAPAN: HTS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 359 JAPAN: HTS MARKET, BY END USER, 2018–2025 (USD MILLION)
10.3.3 INDIA
10.3.3.1 Market growth can be attributed to increasing government funding for the Indian pharmaceutical industry
TABLE 360 INDIA: HTS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 361 INDIA: CELL-BASED ASSAYS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 362 INDIA: 3D CELL CULTURE MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 363 INDIA: SCAFFOLD-BASED TECHNOLOGIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 364 INDIA: HYDROGELS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 365 INDIA: ANIMAL-DERIVED HYDROGELS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 366 INDIA: SCAFFOLD-FREE TECHNOLOGIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 367 INDIA: HTS MARKET, BY PRODUCT AND SERVICE, 2018–2025 (USD MILLION)
TABLE 368 INDIA: CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 369 INDIA: INSTRUMENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 370 INDIA: HTS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 371 INDIA: HTS MARKET, BY END USER, 2018–2025 (USD MILLION)
10.3.4 AUSTRALIA
10.3.4.1 Collaborations between research centers and pharmaceutical companies for drug discovery will drive market growth in Australia
TABLE 372 AUSTRALIA: HTS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 373 AUSTRALIA: CELL-BASED ASSAYS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 374 AUSTRALIA: 3D CELL CULTURE MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 375 AUSTRALIA: SCAFFOLD-BASED TECHNOLOGIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 376 AUSTRALIA: HYDROGELS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 377 AUSTRALIA: ANIMAL-DERIVED HYDROGELS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 378 AUSTRALIA: SCAFFOLD-FREE TECHNOLOGIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 379 AUSTRALIA: HTS MARKET, BY PRODUCT AND SERVICE, 2018–2025 (USD MILLION)
TABLE 380 AUSTRALIA: CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 381 AUSTRALIA: INSTRUMENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 382 AUSTRALIA: HTS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 383 AUSTRALIA: HTS MARKET. BY END USER, 2018–2025 (USD MILLION)
10.3.5 REST OF THE ASIA PACIFIC (ROAPAC)
TABLE 384 ROAPAC: HTS MARKET. BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 385 ROAPAC: CELL-BASED ASSAYS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 386 ROAPAC: 3D CELL CULTURE MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 387 ROAPAC: SCAFFOLD-BASED TECHNOLOGIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 388 ROAPAC: HYDROGELS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 389 ROAPAC: ANIMAL-DERIVED HYDROGELS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 390 ROAPAC: SCAFFOLD-FREE TECHNOLOGIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 391 ROAPAC: HTS MARKET. BY PRODUCT AND SERVICE, 2018–2025 (USD MILLION)
TABLE 392 ROAPAC: CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 393 ROAPAC: INSTRUMENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 394 ROAPAC: HTS MARKET. BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 395 ROAPAC: HTS MARKET. BY END USER, 2018–2025 (USD MILLION)
10.4 REST OF THE WORLD (ROW)
TABLE 396 ROW: HTS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 397 ROW: HTS MARKET. BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 398 ROW: CELL-BASED ASSAYS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 399 ROW: 3D CELL CULTURE MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 400 ROW: SCAFFOLD-BASED TECHNOLOGIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 401 ROW: HYDROGELS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 402 ROW: ANIMAL-DERIVED HYDROGELS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 403 ROW: SCAFFOLD-FREE TECHNOLOGIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 404 ROW: HTS MARKET. BY PRODUCT AND SERVICE, 2018–2025 (USD MILLION)
TABLE 405 ROW: CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 406 ROW: INSTRUMENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 407 ROW: HTS MARKET. BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 408 ROW: HTS MARKET. BY END USER, 2018–2025 (USD MILLION)
10.4.1 LATIN AMERICA
10.4.1.1 The emerging pharmaceutical industry in Latin America will drive market growth for HTS
TABLE 409 LATIN AMERICA: HTS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 410 LATIN AMERICA: CELL-BASED ASSAYS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 411 LATIN AMERICA: 3D CELL CULTURE MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 412 LATIN AMERICA: SCAFFOLD-BASED TECHNOLOGIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 413 LATIN AMERICA: HYDROGELS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 414 LATIN AMERICA: ANIMAL-DERIVED HYDROGELS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 415 LATIN AMERICA: SCAFFOLD-FREE TECHNOLOGIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 416 LATIN AMERICA: HTS MARKET, BY PRODUCT AND SERVICE, 2018–2025 (USD MILLION)
TABLE 417 LATIN AMERICA: CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 418 LATIN AMERICA: INSTRUMENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 419 LATIN AMERICA: HTS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 420 LATIN AMERICA: HTS MARKET, BY END USER, 2018–2025 (USD MILLION)
10.4.2 MIDDLE EAST AND AFRICA
10.4.2.1 Market growth can be attributed to changing demographics and favorable government policies for pharmaceutical R&D
TABLE 421 MIDDLE EAST AND AFRICA: HTS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 422 MIDDLE EAST AND AFRICA: CELL-BASED ASSAYS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 423 MIDDLE EAST AND AFRICA: 3D CELL CULTURE MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 424 MIDDLE EAST AND AFRICA: SCAFFOLD-BASED TECHNOLOGIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 425 MIDDLE EAST AND AFRICA: HYDROGELS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 426 MIDDLE EAST AND AFRICA: ANIMAL-DERIVED HYDROGELS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 427 MIDDLE EAST AND AFRICA: SCAFFOLD-FREE TECHNOLOGIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 428 MIDDLE EAST AND AFRICA: HTS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 429 MIDDLE EAST AND AFRICA: HTS MARKET, BY PRODUCT AND SERVICE, 2018–2025 (USD MILLION)
TABLE 430 MIDDLE EAST AND AFRICA: CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 431 MIDDLE EAST AND AFRICA: INSTRUMENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 432 MIDDLE EAST AND AFRICA: HTS MARKET, BY END USER, 2018–2025 (USD MILLION)
11 COMPETITIVE LANDSCAPE
11.1 OVERVIEW
FIGURE 27 MARKET EVALUATION FRAMEWORK
11.2 REVENUE ANALYSIS OF TOP MARKET PLAYERS
TABLE 433 MARKET SHARE ANALYSIS: 2019
11.3 HIGH-THROUGHPUT SCREENING MARKET: COMPANY EVALUATION QUADRANT, 2019
11.3.1 STARS
11.3.2 EMERGING LEADERS
11.3.3 PERVASIVE COMPANIES
11.3.4 EMERGING COMPANIES
FIGURE 28 HIGH-THROUGHPUT SCREENING MARKET: COMPANY EVALUATION MATRIX, 2019
11.4 HIGH-THROUGHPUT SCREENING MARKET: START-UP/SME EVALUATION MATRIX, 2019
11.4.1 PROGRESSIVE COMPANIES
11.4.2 STARTING BLOCKS
11.4.3 RESPONSIVE COMPANIES
11.4.4 DYNAMIC COMPANIES
FIGURE 29 HIGH-THROUGHPUT SCREENING MARKET: STARTUP/SME EVALUATION MATRIX, 2019
11.5 KEY MARKET DEVELOPMENTS
11.5.1 KEY PRODUCT LAUNCHES
11.5.2 KEY ACQUISITIONS
11.5.3 KEY ALLIANCES, AGREEMENTS, AND COLLABORATIONS
11.5.4 KEY EXPANSIONS
12 COMPANY PROFILES
(Business Overview, Products Offered, Recent Developments, MnM View)*
12.1 THERMO FISHER SCIENTIFIC INC.
FIGURE 30 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2019)
12.2 AGILENT TECHNOLOGIES, INC.
FIGURE 31 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2019)
12.3 MERCK KGAA
FIGURE 32 MERCK KGAA: COMPANY SNAPSHOT (2019)
12.4 DANAHER CORPORATION
FIGURE 33 DANAHER CORPORATION: COMPANY SNAPSHOT (2019)
12.5 PERKINELMER, INC.
FIGURE 34 PERKINELMER, INC.: COMPANY SNAPSHOT (2019)
12.6 TECAN GROUP LTD.
FIGURE 35 TECAN GROUP LTD.: COMPANY SNAPSHOT (2019)
12.7 AXXAM S.P.A.
12.8 BIO-RAD LABORATORIES, INC.
FIGURE 36 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2019)
12.9 PROMEGA CORPORATION
12.10 CORNING INCORPORATED
FIGURE 37 CORNING INCORPORATED: COMPANY SNAPSHOT (2019)
12.11 CHARLES RIVER LABORATORIES
FIGURE 38 CHARLES RIVER LABORATORIES: COMPANY SNAPSHOT (2019)
12.12 EUROFINS SCIENTIFIC
FIGURE 39 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2019)
12.13 HAMILTON COMPANY
12.14 LONZA
FIGURE 40 LONZA: COMPANY SNAPSHOT (2020)
12.15 REPROCELL INC.
12.16 AURORA BIOMED
12.17 BMG LABTECH
12.18 DIANA BIOTECHNOLOGIES S.R.O.
12.19 NANOTEMPER TECHNOLOGIES GMBH
12.20 CREATIVE BIOLABS
12.21 BIOMAT SRL
*Business Overview, Products Offered, Recent Developments, MnM View might not be captured in case of unlisted companies.
13 APPENDIX
13.1 DISCUSSION GUIDE
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.3 AVAILABLE CUSTOMIZATIONS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS
